0001144204-18-041786.txt : 20180803 0001144204-18-041786.hdr.sgml : 20180803 20180803060216 ACCESSION NUMBER: 0001144204-18-041786 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 57 CONFORMED PERIOD OF REPORT: 20180630 FILED AS OF DATE: 20180803 DATE AS OF CHANGE: 20180803 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Semler Scientific, Inc. CENTRAL INDEX KEY: 0001554859 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 261367393 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36305 FILM NUMBER: 18990235 BUSINESS ADDRESS: STREET 1: 911 BERN COURT, SUITE 110 CITY: SAN JOSE STATE: CA ZIP: 95112 BUSINESS PHONE: 408-627-4557 MAIL ADDRESS: STREET 1: 911 BERN COURT, SUITE 110 CITY: SAN JOSE STATE: CA ZIP: 95112 10-Q 1 tv499575_10q.htm FORM 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended June 30, 2018

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period from ___ to ___

Commission File Number 001-36305

SEMLER SCIENTIFIC, INC.

(Exact name of registrant as specified in its charter)

Delaware	26-1367393
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification Number)

911 Bern Court, Suite 110

San Jose, CA 95112

(Address of principal executive offices) (Zip Code)

(877) 774-4211

(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.:

Large Accelerated Filer	¨		Accelerated Filer	¨

Non-Accelerated Filer	¨	(Do not check if a smaller reporting company)	Smaller Reporting Company	x

Emerging growth company	x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

As of July 31, 2018, there were 6,035,496 shares of the issuer’s common stock, $0.001 par value per share, outstanding.

TABLE OF CONTENTS

		Page
Part I.	Financial Information	1

Item 1.	Financial Statements	1
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	14
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	19
Item 4.	Controls and Procedures	19

Part II.	Other Information	20

Item 1.	Legal Proceedings	20
Item 1A.	Risk Factors	20
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	20
Item 3.	Defaults upon Senior Securities	20
Item 4.	Mine Safety Disclosures	20
Item 5.	Other Information	20
Item 6.	Exhibits	20

Signatures		21

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This quarterly report on Form 10-Q contains forward-looking statements. Such forward-looking statements include those that express plans, anticipation, intent, contingency, goals, targets or future development and/or otherwise are not statements of historical fact. These forward-looking statements are based on our current expectations and projections about future events and they are subject to risks and uncertainties known and unknown that could cause actual results and developments to differ materially from those expressed or implied in such statements.

In some cases, you can identify forward-looking statements by terminology, such as “expects,” “anticipates,” “intends,” “estimates,” “plans,” “believes,” “seeks,” “may,” “should,” “continue,” “could” or the negative of such terms or other similar expressions. Accordingly, these statements involve estimates, assumptions and uncertainties that could cause actual results to differ materially from those expressed in them. Any forward-looking statements are qualified in their entirety by reference to the factors discussed throughout this report.

You should read this quarterly report and the documents that we reference herein and therein and have filed as exhibits to this report, completely and with the understanding that our actual future results may be materially different from what we expect. You should assume that the information appearing in this quarterly report is accurate as of the date of this report only. Because the risk factors referred to above could cause actual results or outcomes to differ materially from those expressed in any forward-looking statements made by us or on our behalf, you should not place undue reliance on any forward-looking statements. These risks and uncertainties, along with others, are described above under the heading “Risk Factors” in our annual report on Form 10-K filed with the Securities and Exchange Commission, or SEC, on March 8, 2018. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. New factors emerge from time to time, and it is not possible for us to predict which factors will arise. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. We qualify all of the information presented in this quarterly report, and particularly our forward-looking statements, by these cautionary statements.

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements.

Semler Scientific, Inc.

Condensed Statements of Operations

(In thousands of U.S. Dollars, except share and per share data)

	(Unaudited)						(Unaudited)
	For the three months ended June 30						For the six months ended June 30
	2018			2017			2018			2017

Revenues	$	5,484		$	2,578		$	9,947		$	4,633

Operating expenses:
Cost of revenues		680			592			1,384			1,131
Engineering and product development		489			474			856			913
Sales and marketing		1,779			1,164			3,484			2,153
General and administrative		1,001			902			1,875			1,740
Total operating expenses		3,949			3,132			7,599			5,937
Income (loss) from operations		1,535			(554	)		2,348			(1,304	)

Interest expense		(9	)		(72	)		(56	)		(145	)
Related party interest expense		(72	)		(43	)		(131	)		(86	)
Loss on extinguishment of loans		-			(179	)		-			(179	)
Other expense		(1	)		(2	)		(2	)		(8	)
Other expense		(82	)		(296	)		(189	)		(418	)

Net income (loss)	$	1,453		$	(850	)	$	2,159		$	(1,722	)

Net income (loss) per share:
Basic	$	0.24		$	(0.16	)	$	0.36		$	(0.33	)
Diluted	$	0.19		$	(0.16	)	$	0.29		$	(0.33	)

Weighted average number of shares used in computing: basic and diluted loss per share

Basic		5,982,711			5,340,234			5,953,818			5,286,179
Diluted		7,534,846			5,340,234			7,403,498			5,286,179

See accompanying notes to unaudited condensed financial statements.

Semler Scientific, Inc.

Condensed Balance Sheets

(In thousands of U.S. Dollars, except share and per share data)

	*(Unaudited)*
	June 30,			December 31,
	2018			2017

Assets

Current Assets:
Cash	$	2,009		$	1,457
Trade accounts receivable, net of allowance for doubtful accounts of $35 and $35, respectively		1,850			1,315
Prepaid expenses and other current assets		216			111
Total current assets		4,075			2,883

Assets for lease, net		975			1,147
Property and equipment, net		247			193
Long-term deposits		15			15
Total assets	$	5,312		$	4,238

Liabilities and Stockholders' Equity (Deficit)

Current liabilities:
Accounts payable	$	185		$	488
Accrued expenses		2,256			2,670
Deferred revenue		535			531
Accrued interest		-			168
Accrued interest – related party		41			28
Loans payable net of debt discount of $0 and $9, respectively		44			1,018
Related party loans payable net of debt discount of $6 and $13, respectively		2,017			237
Total current liabilities		5,078			5,140

Long-term liabilities:

Deferred rent		12			13
Loans payable, less current portion		6			26
Related party loans payable, less current portion		-			1,642
Total long-term liabilities		18			1,681

Stockholders' equity (deficit):
Common stock, $0.001 par value; 50,000,000 shares authorized; 6,048,397 and 5,902,244 shares issued, and 6,023,397 and 5,877,244 outstanding (treasury shares of 25,000 and 25,000), respectively		6			6
Additional paid-in capital		24,484			23,843
Accumulated deficit		(24,274	)		(26,432	)

Total stockholders' equity (deficit)		216			(2,583	)

Total liabilities and stockholders' equity (deficit)	$	5,312		$	4,238

See accompanying notes to unaudited condensed financial statements.

Semler Scientific, Inc.

Condensed Statements of Cash Flows

(In thousands of U.S. Dollars)

	*(Unaudited)*
	Six months ended June 30
	2018			2017

CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$	2,159		$	(1,722	)

Reconciliation of Net Income (Loss) to Net Cash Provided by Operating Activities:
Amortization of debt discount		16			80
Accretion of non-cash interest		135			44
Loss on extinguishment of debt		-			179
Depreciation		249			267
Loss on disposal of assets for lease		107			142
Allowance for doubtful accounts		20			5
Stock-based compensation expense		331			165
Changes in Operating Assets and Liabilities:
Trade accounts receivable		(535	)		(13	)
Prepaid expenses and other current assets		(105	)		(7	)
Accounts payable		(303	)		96
Accrued expenses		(570	)		505
Deferred revenue		4			189
Net Cash Provided By (Used in) Operating Activities		1,508			(70	)

CASH FLOWS FROM INVESTING ACTIVITIES:
Additions to property and equipment		(105	)		(12	)
Purchase of assets for lease		(138	)		(591	)
Net Cash Used in Investing Activities		(243	)		(603	)

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock		-			475
Exercise of warrants		64			-
Exercise of stock options		245			78
Proceeds from loans payable		-			63
Payments of loans payable		(1,022	)		(69	)
Net Cash (Used in) Provided by Financing Activities		(713	)		547

INCREASE (DECREASE) IN CASH		552			(126	)
CASH, BEGINNING OF PERIOD		1,457			622

CASH, END OF PERIOD	$	2,009		$	496
Cash paid for interest	$	191		$	7

Supplemental disclosure of noncash financing activity:
Reclassification of accrued interest to debt upon extinguishment	$	-		$	162
Fair value of warrants issued to lenders	$	-		$	288

See accompanying notes to unaudited condensed financial statements

Semler Scientific, Inc.

Notes to Condensed Financial Statements

Unaudited

(In thousands of U.S. Dollars, except share and per share data)

Basis of Presentation

Semler Scientific, Inc., a Delaware corporation (“Semler” or “the Company”), prepared the unaudited interim financial statements included in this report in accordance with United States generally accepted accounting principles (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this quarterly report on Form 10-Q should be read in conjunction with the audited financial statements and notes thereto included in the Company’s annual report on Form 10-K for the year ended December 31, 2017 filed with the SEC on March 8, 2018 (the “Annual Report”). In the opinion of management, these financial statements include all adjustments (consisting of normal recurring adjustments) necessary for a fair statement of the financial position, results of operations and cash flows for the periods presented. The results of operations for the interim periods shown in this report are not necessarily indicative of the results that may be expected for any future period, including the full year.

Recently Issued Accounting Pronouncements

Accounting Pronouncements Recently Adopted

In November 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2015-17, Balance Sheet Classification of Deferred Taxes, to reduce complexity and simplify the reporting of deferred income tax liabilities and assets. The amendments in this ASU require that all deferred tax liabilities and assets be classified as noncurrent in a classified balance sheet. The current requirement that deferred tax liabilities and assets of a tax-paying component of an entity be offset and presented as a single amount is not affected by the amendment of this ASU. This standard is effective for the Company’s annual periods beginning after December 15, 2017 and interim periods within annual periods beginning after December 15, 2018, with earlier application permitted. The Company adopted the new standard in the first quarter of 2018. The Company maintains full valuation allowances on all deferred tax balances, and therefore, the adoption of this standard did not have a material impact on its financial statements.

In May 2017, the FASB issued ASU No. 2017-09, Compensation — Stock Compensation (Topic 718) — Scope of Modification Accounting. This ASU requires modification accounting for a change in terms or conditions of a share-based payment award only if the fair value, the vesting condition, or the classification of the award (as liability or equity) changes as a result of the changes in terms or conditions. The amendments, which are to be applied prospectively to modifications after adoption, are effective for the Company's annual periods beginning after December 15, 2017, with early adoption permitted. The Company adopted the new standard in the first quarter of 2018 and it did not have a material effect on the Company's financial position or results of operations.

Accounting Pronouncements Not Yet Adopted

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”). The amendment in this ASU provides guidance on the revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The core principle of ASU 2014-09 provides guidance to identify the performance obligations under the contract(s) with a customer and how to allocate the transaction price to the performance obligations in the contract. It further provides guidance to recognize revenue when (or as) the entity satisfies a performance obligation. This standard will replace most existing revenue recognition guidance. On August 8, 2015, the FASB issued ASU 2015-14, which defers the effective date of ASU 2014-09 by one year, and permits early adoption as long as the adoption date is not before the original public entity effective date. This standard is effective for the Company’s annual periods beginning after December 31, 2018 and interim periods within annual periods beginning after December 15, 2018, with early adoption permitted for the year ended December 31, 2017. Since the issuance of ASU 2014-09, the FASB has issued several amendments that clarify certain points, including ASU 2016-08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net), ASU No. 2016-10, Identifying Performance Obligations and Licensing, ASU No. 2016-11, Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16 Pursuant to Staff Announcements at the March 3, 2016 Emerging Issues Task Force Meeting, and ASU No. 2016-12, Narrow-Scope Improvements and Practical Expedients, and ASU No. 2016-20, Technical Corrections and Improvements to Topic 606. The updated revenue standard allows two methods of adoption: (1) retrospectively to each prior period presented (“full retrospective method”), or (2) retrospectively with the cumulative effect recognized in retained earnings as of the date of adoption ("modified retrospective method"). The new standard further requires new disclosures about contracts with customers, including the significant judgments the company has made when applying the guidance. The Company will adopt the new standard effective January 1, 2019, using the modified retrospective transition method. The Company is currently evaluating the impact that this new standard will have on its financial statements.

Semler Scientific, Inc.

Notes to Condensed Financial Statements

Unaudited

(In thousands of U.S. Dollars, except share and per share data)

In January 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) ("ASU 2016-02"). Under the new guidance in ASU 2016-02, lessees will be required to recognize the following for all leases (with the exception of short-term leases) at the commencement date: 1) A lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and 2) A right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. Under the new guidance, lessor accounting is largely unchanged, however, certain targeted improvements were made. ASU 2016-02 also simplifies the accounting for sale and leaseback transactions. Lessees (for capital and operating leases) and lessors (for sales-type, direct financing, and operating leases) must apply a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. Lessees and lessors may not apply a full retrospective transition approach. The new standard also requires expanded disclosures regarding leasing arrangements. This standard is effective for the Company’s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company is currently evaluating the impact that this new standard will have on its financial statements.

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). This ASU requires timelier recording of credit losses on loans and other financial instruments held. Instead of reserves based on a current probability analysis, ASU 2016-13 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. All organizations will now use forward-looking information to better inform their credit loss estimates. ASU 2016-13 requires enhanced disclosures regarding significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization’s portfolio. These disclosures include qualitative and quantitative requirements that provide information about the amounts recorded in the financial statements. In addition, ASU 2016-13 amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. This standard is effective for the Company’s fiscal years beginning after December 15, 2020. The Company will adopt the new standard in fiscal year 2021. The Company is currently evaluating the effect the new standard will have on its financial statements.

In June 2018, the FASB issued ASU No. 2018-07, Compensation — Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (“ASU 2018-07”). This ASU expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. An entity should apply the requirements of Topic 718 to nonemployee awards except for specific guidance on inputs to an option pricing model and the attribution of costs. The ASU specifies that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards. This standard is effective for the Company’s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company is currently evaluating the impact that this new standard will have on its financial statements.

Going Concern

From inception through the third quarter of 2017, the Company incurred recurring losses as a result of costs and expenses related to the Company’s marketing and other promotional activities, and continued research and development of its products. The Company generated a net profit for the six months ended June 30, 2018. As of June 30, 2018, the Company has negative working capital of $1,003, cash of $2,009 and stockholders’ equity of $216. The Company’s principal sources of cash have included the issuance of equity securities, to a lesser extent, borrowings under loan agreements and revenues from leasing its products. To increase revenues, the Company’s operating expenses will continue to grow and, as a result, the Company will need to generate significant additional revenues to maintain profitability.

The Company’s financial statements as of June 30, 2018 have been prepared under the assumption that the Company will continue as a going concern. The Company’s ability to continue as a going concern is dependent upon its ability to attain further operating efficiencies and, ultimately, to generate additional revenues or raise additional capital. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. The Company can give no assurances that additional revenues that the Company may be able to generate nor any additional capital that the Company is able to obtain, if any, will be sufficient to meet the Company’s needs. The foregoing conditions raise substantial doubt about the Company’s ability to continue as a going concern.

Semler Scientific, Inc.

Notes to Condensed Financial Statements

Unaudited

(In thousands of U.S. Dollars, except share and per share data)

Assets for Lease, net

Assets for lease consist of the following:

	June 30, 2018			December 31, 2017

Assets for lease	$	1,812		$	1,847
Less: accumulated depreciation		(837	)		(700	)
Assets for lease, net	$	975		$	1,147

Depreciation expense amounted to $101 and $85 for the three months ended June 30, 2018 and June 30, 2017, respectively. Depreciation expense amounted to $198 and $171 for the six months ended June 30, 2018 and June 30, 2017, respectively. Reduction to accumulated depreciation for returned items was $28 and $38 for the three months ended June 30, 2018 and June 30, 2017, respectively. Reduction to accumulated depreciation for returned items was $61 and $93 for the six months ended June 30, 2018 and June 30, 2017, respectively. The Company recognized a loss on disposal of assets for lease in the amount of $38 and $55 for the three months ended June 30, 2018 and June 30, 2017, respectively. The Company recognized a loss on disposal of assets for lease in the amount of $107 and $142 for the six months ended June 30, 2018 and June 30, 2017, respectively.

Property and Equipment, net

Capital assets consist of the following:

	June 30, 2018			December 31, 2017

Capital assets	$	427		$	322
Less: accumulated depreciation		(180	)		(129	)
Capital assets, net	$	247		$	193

Depreciation expense amounted to $26 and $47 for the three months ended June 30, 2018 and June 30, 2017, respectively. Depreciation expense amounted to $51 and $95 for the six months ended June 30, 2018 and June 30, 2017, respectively.

Accrued Expenses

Accrued expenses consist of the following:

	June 30, 2018		December 31, 2017

Compensation (1)	$	1,964	$	2,275
Board of directors fees (2)		15		148
Miscellaneous accruals		277		247
Total accrued expenses	$	2,256	$	2,670

____________

The balance of accrued compensation includes normal accruals for commissions, bonuses, paid time off and other accrued payroll items. In addition, three employees, including the Company’s Chief Executive Officer (“CEO”), agreed to further defer amounts accrued to them as of December 31, 2017. The Company agreed to further delay and continue to accrue these amounts and increase the balance owed by 1% per month beginning January 1, 2017 to no later than January 31, 2019. As of June 30, 2018, the deferred amounts plus additional 1% accruals owed to the CEO were paid in full and the balance was $0.

Two members of the Company’s board of directors agreed to further defer fees earned from August 2016 to July 2017. The Company agreed to further delay and continue to accrue these amounts and increase the balance owed by 1% per month beginning January 1, 2018 to no later than January 1, 2019. As of June 30, 2018, these deferred amounts plus additional 1% accruals were paid in full and the balance was $0.

Semler Scientific, Inc.

Notes to Condensed Financial Statements

Unaudited

(In thousands of U.S. Dollars, except share and per share data)

Concentration of Credit Risk

Credit risk is the risk of loss from amounts owed by the financial counterparties. Credit risk can occur at multiple levels; as a result of broad economic conditions, challenges within specific sectors of the economy, or from issues affecting individual companies. Financial instruments that potentially subject the Company to credit risk consist of cash and accounts receivable.

The Company maintains cash with major financial institutions. The Company’s cash consists of bank deposits held with banks that, at times, exceed federally insured limits. The Company limits its credit risk by dealing with counterparties that are considered to be of high credit quality and by performing periodic evaluations of the relative credit standing of these financial institutions.

Management periodically monitors the creditworthiness of its customers and believes that it has adequately provided for any exposure to potential credit loss. For the three months ended June 30, 2017, one customer accounted for 56.1% of the Company’s revenue. For the six months ended June 30, 2017, one customer accounted for 56.7% of the Company’s revenue. As of December 31, 2017, two customers accounted for 56.6% and 23.9% of the Company’s accounts receivable, respectively. For the three months ended June 30, 2018, two customers accounted for 50.3% and 22.5% of the Company’s revenue. For the six months ended June 30, 2018, two customers accounted for 53.9% and 17.7% of the Company’s revenue. As of June 30, 2018, two customers accounted for 45.1% and 37.7% of the Company’s accounts receivable.

Facilities Leases

The Company recognized facilities lease expenses of $18 and $17 for the three months ended June 30, 2018 and 2017, respectively. The Company recognized facilities lease expenses of $35 and $34 for the six months ended June 30, 2018 and 2017, respectively.

On September 23, 2014, the Company entered into a 36-month lease agreement for office space for the sales and marketing team located in Menlo Park, CA. The lease term commenced February 1, 2015 and was effective through January 31, 2018. Payments required under the terms of the lease were $17.0 per month from February 2015 to January 2016, $17.5 per month from February 2016 to January 2017, and $18.0 per month from February 2017 to January 2018. The Company anticipates no future lease payments for the year ended December 31, 2018. On July 15, 2015, the Company entered into a 30-month sublease agreement for the Menlo Park office space, which commenced August 1, 2015 and was effective through the term of the lease, January 31, 2018. Payments required to the Company under the terms of the sublease were $15.5 per month from August 2015 to July 2016, $16.0 per month from August 2016 to July 2017, and $16.5 per month from August 2017 to January 2018. The Company anticipates receipt of no future payments for the year ended December 31, 2018.

Loans Payable

	June 30, 2018					December 31, 2017
Lender	Long-term		Short-term			Long-term		Short-term
Loans from Related Parties
Chang Family Trust			$	1,216		$	1,126
Chang Family Trust				557			516
Glenn J. Krevlin				250				$	250

Other Loans
Accredited Investor				-					700
Accredited Investor				-					160
Accredited Investor				-					80
Ascentium Capital, LLC				-					22
Ascentium Capital, LLC	$	4		28			16		26
Royal Bank America Leasing, L.P.				5					28
Ascentium Capital, LLC		2		11			10		11

Total		6		2,067			1,668		1,277
Debt Discounts		-		(6	)		-		(22	)
Total, net of debt discounts	$	6	$	2,061		$	1,668	$	1,255

Semler Scientific, Inc.

Notes to Condensed Financial Statements

Unaudited

(In thousands of U.S. Dollars, except share and per share data)

Loans from Related Parties

On January 15, 2016, the Company entered into a loan agreement with the Chang Family Trust, one of its significant stockholders. Pursuant to the loan agreement, the Company obtained a $1,000 unsecured loan, which initially had a 24-month term, at a fixed interest rate of 10% per annum. Under the loan agreement, the Company will pay $1,000 of principal plus all accrued and unpaid interest at maturity. The Company may prepay the notes at any time prior to maturity without penalty. The notes must be repaid prior to maturity in the event of default, and the Company agreed not to incur additional indebtedness in excess of $50 without the lender’s prior consent, which is not to be unreasonably withheld. In connection therewith, the Company issued the Chang Family Trust a two-year warrant to purchase 114,286 shares of its common stock at an exercise price of $1.75 per share. The relative fair value of this warrant was recorded as a debt discount on the Company’s balance sheet and partially offsets the total balance due for loans payable. The warrants were exercised in full in December 2017 and are no longer outstanding. As of the date of this filing, the Company is in compliance with all terms of this loan.

On January 21, 2016, the Company entered into a second loan agreement with the Chang Family Trust. Pursuant to this loan agreement, the Company obtained a $500 unsecured loan, which initially had a 24-month term at a fixed interest rate of 5% per annum. Under this loan agreement, the Company will pay $500 of principal plus all accrued and unpaid interest at maturity. The Company may prepay the notes at any time prior to maturity without penalty. The notes must be repaid prior to maturity in the event of default, and the Company agreed not to incur additional indebtedness in excess of $50 without the lender’s prior consent, which is not to be unreasonably withheld. In connection therewith, the Company issued the Chang Family Trust a two-year warrant to purchase 114,286 shares of its common stock at an exercise price of $1.75 per share. The relative fair value of this warrant was recorded as a debt discount on the Company’s balance sheet and partially offsets the total balance due for loans payable. The warrants were exercised in full in December 2017 and are no longer outstanding. As of the date of this filing, the Company is in compliance with all terms of this loan.

On May 2, 2017, the Company entered into an amendment regarding the outstanding promissory notes and warrants issued in January 2016 to the Chang Family Trust. As amended, the maturity date for each note has now been extended by 12 months to January 2019, and the interest rate on the $500 note has been increased to 10.0% per annum for the final 12 months of its term. In each case, interest will accrue on the unpaid principal and accrued interest as of the original two-year maturity date in the final year term of the notes. The other terms of the notes remain unchanged. Additionally, as issued, the warrants were not exercisable, absent receipt of stockholder approval, if after such exercise the holder would be the beneficial owner of more than 19.99% of the Company’s common stock. This condition was removed by the amendments, and accordingly, stockholder approval is no longer required. In connection with the foregoing amendment, the Company issued the Chang Family Trust a warrant to purchase 134,616 shares of its common stock at an exercise price of $2.60 per share. In accordance with FASB ASC 815, these warrants were classified within permanent equity. The warrant expires January 21, 2022, three years after the latest maturity date of the promissory notes, as amended. As part of the amendment, the fair value of the warrants were considered in the calculation when determining whether this amendment resulted in a modification or extinguishment of the original loans in accordance with FASB ASC 470, the Company recorded the amendment as an extinguishment of the original loans which resulted in a loss on extinguishment of $179 as recorded in the statements of operations.

On November 21, 2016, the Company entered into a loan agreement with Glenn J. Krevlin, one of its significant stockholders. Pursuant to the loan agreement, the Company obtained a $250 unsecured loan for a 24-month term at a fixed interest rate of 10% per annum. Under the loan agreement, the Company will pay $250 of principal plus all accrued but unpaid interest at maturity. The notes may be prepaid at any time prior to maturity without penalty. The notes must be repaid prior to maturity in the event of default. In connection therewith, the Company issued the accredited investor a two-year warrant to purchase 28,378 shares of common stock at an exercise price of $1.85 per share. The warrants were not able to be exercised absent receipt of stockholder approval if after such exercise the holder would be the beneficial owner of more than 9.99% of the Company’s common stock. The relative fair value of this warrant was recorded as a debt discount on the Company’s balance sheet and partially offsets the total balance due for loans payable. As of the date of this filing, the Company is in compliance with all terms of this loan, and the warrants were exercised in full in January 2018.

Other Loans

On March 31, 2016, the Company entered into a loan agreement with an accredited investor. Pursuant to the loan agreement, the Company obtained a $700 unsecured loan for a 24-month term at a fixed interest rate of 10% per annum. Under the loan agreement, the Company will pay $700 of principal plus all accrued but unpaid interest at maturity. The notes may be prepaid at any time prior to maturity without penalty. The notes must be repaid prior to maturity in the event of default. In connection therewith, the Company issued the accredited investor a two-year warrant to purchase 79,459 shares of common stock at an exercise price of $1.85 per share. The warrants were not able to be exercised absent receipt of stockholder approval if after such exercise the holder would be the beneficial owner of more than 4.99% of the Company’s common stock. The relative fair value of this warrant was recorded as a debt discount on the Company’s balance sheet and partially offsets the total balance due for loans payable. The warrants were exercised in full in November 2017. During the quarter ended March 31, 2018, the Company has paid this loan and all associated interest in full.

Semler Scientific, Inc.

Notes to Condensed Financial Statements

Unaudited

(In thousands of U.S. Dollars, except share and per share data)

On April 5, 2016, the Company entered into a loan agreement with an accredited investor. Pursuant to the loan agreement, the Company obtained a $160 unsecured loan for a 24-month term at a fixed interest rate of 10% per annum. Under the loan agreement, the Company will pay $160 of principal plus all accrued but unpaid interest at maturity. The notes may be prepaid at any time prior to maturity without penalty. The notes must be repaid prior to maturity in the event of default. In connection therewith, the Company issued the accredited investor a two-year warrant to purchase 18,162 shares of common stock at an exercise price of $1.85 per share. The warrants may not be exercised absent receipt of stockholder approval if after such exercise the holder would be the beneficial owner of more than 4.99% of the Company’s common stock. The relative fair value of this warrant was recorded as a debt discount on the Company’s balance sheet and partially offsets the total balance due for loans payable. The warrants were fully exercised as of December 31, 2017. As of the date of this filing, the Company has paid this loan and all associated interest in full.

On May 20, 2016, the Company entered into a loan agreement with an accredited investor. Pursuant to the loan agreement, the Company obtained a $80 unsecured loan for a 24-month term at a fixed interest rate of 10% per annum. Under the loan agreement, the Company will pay $80 of principal plus all accrued but unpaid interest at maturity. The notes may be prepaid at any time prior to maturity without penalty. The notes must be repaid prior to maturity in the event of default. In connection therewith, the Company issued the accredited investor a two-year warrant to purchase 9,081 shares of common stock at an exercise price of $1.85 per share. The warrants may not be exercised absent receipt of stockholder approval if after such exercise the holder would be the beneficial owner of more than 4.99% of the Company’s common stock. The relative fair value of this warrant was recorded as a debt discount on the Company’s balance sheet and partially offsets the total balance due for loans payable. The warrants were partially exercised in December 2017 for an aggregate of 7,323 shares of our common stock with the remainder being exercised in March 2018. As of the date of this filing, the Company has paid this loan and all associated interest in full.

The Company uses the Black-Scholes pricing model to determine the fair value of warrants. The fair value of each warrant is estimated on the date of grant. There were no warrants issued during the three or six months ended June 30, 2018. The fair value of warrants issued in conjunction with the related party loans during the three and six months ended June 30, 2017 was $288. The fair value of the warrants granted is estimated on the date of grant using the Black-Scholes pricing model and the following assumptions for the periods presented:

	Three months ended June 30,						Six months ended June 30,
	2018			2017			2018			2017
Expected term (in years)		-			4.75			-			4.75
Risk-free interest rate		-	%		1.27	%		-	%		1.27	%
Expected volatility		-	%		104.6	%		-	%		104.6	%
Expected dividend rate		-	%		-	%		-	%		-	%

On July 8, 2016, the Company entered into an additional software license financing agreement with Ascentium Capital, LLC. Pursuant to the agreement, the Company obtained a $74 loan for a 36-month term at a fixed interest rate of 8.9% per annum. Under the loan agreement, the Company agreed to make monthly payments of $2.4 of principal and accrued interest. The loan may be prepaid at any time prior to maturity without penalty. The agreement provides for customary events of default. As of the date of this filing, the Company is in compliance with all terms of this loan.

On July 11, 2016, the Company entered into a secured equipment financing agreement with Royal Bank America Leasing, L.P. Pursuant to the agreement, the Company obtained a $140 loan for a 36-month term at a fixed interest rate of 7.3% per annum, which is secured by related equipment. The loan is to be disbursed in three installments. The first installment was for $37. The second installment for $47 will be disbursed in July 2017, and the third installment for $56 will be disbursed in July 2018. Under the loan agreement, the Company will pay $3.5 of principal and accrued interest for each of the first 12 months (July 2016 through July 2017), $4.4 of principal and accrued interest for each of months 13-24 (July 2017 through July 2018), and $5.3 of principal and accrued interest for each of months 25-36 (July 2018 through July 2019). The loan may be prepaid at any time only in accordance with the agreement. The agreement provides for customary events of default. The Company elected not to receive the third installment of this loan and as a result, as of July 2018, this loan and all associated interest have been paid in full.

On October 2, 2016, the Company entered into a secured equipment financing agreement with Ascentium Capital, LLC. Pursuant to the agreement, the Company obtained a $33 loan for a 36-month term at a fixed interest rate of 9.1% per annum. Under the loan agreement, the Company agreed to make monthly payments of $1.0 of principal and accrued interest. The loan may be prepaid at any time prior to maturity without penalty. The agreement provides for customary events of default. As of the date of this filing, the Company is in compliance with all terms of this loan.

Semler Scientific, Inc.

Notes to Condensed Financial Statements

Unaudited

(In thousands of U.S. Dollars, except share and per share data)

On April 1, 2017, the Company entered into a software license financing agreement with Ascentium Capital, LLC. Pursuant to the agreement, the Company obtained a $63 loan for a 12-month term at a fixed interest rate of 10.3% per annum to finance its upfront software licensing fee. The Company agreed to pay $5.6 of principal and accrued interest for each month of the term. The loan may be prepaid at any time prior to maturity without penalty. The agreement provides for customary events of default. In April 2018, the Company repaid this loan and it is no longer outstanding.

For the three months ended June 30, 2018 and 2017, interest expense was $82 and $115, respectively, which included amortization of the debt discount of $4 and $28, respectively. For the six months ended June 30, 2018 and 2017, interest expense was $187 and $231, respectively, which included amortization of debt discount of $16 and $80, respectively.

Indemnification Obligations

The Company enters into agreements with customers, partners, lenders, consultants, lessors, contractors, sales representatives and parties to certain transactions in the ordinary course of the Company’s business. These agreements may require the Company to indemnify the other party against third party claims alleging that its product infringes a patent or copyright. Certain of these agreements require the Company to indemnify the other party against losses arising from: a breach of representations or covenants, claims relating to property damage, personal injury or acts or omissions of the Company, its employees, agents or representatives. The Company has also agreed to indemnify the directors and certain of the officers and employees in accordance with the by-laws of the Company. These indemnification provisions will vary based upon the nature and terms of the agreements. In many cases, these indemnification provisions do not contain limits on the Company’s liability, and the occurrence of contingent events that will trigger payment under these indemnities is difficult to predict. As a result, the Company cannot estimate its potential liability under these indemnities. The Company believes that the likelihood of conditions arising that would trigger these indemnities is remote and, historically, the Company had not made any significant payment under such indemnification provisions. Accordingly, the Company has not recorded any liabilities relating to these agreements. In certain cases, the Company has recourse against third parties with respect to the aforesaid indemnities, and the Company believes it maintains adequate levels of insurance coverage to protect the Company with respect to potential claims arising from such agreements.

Stock Option Plan

The Company’s stock-based compensation program is designed to attract and retain employees while also aligning employees' interests with the interests of its stockholders. Stock options have been granted to employees under the stockholder-approved 2007 Key Person Stock Option Plan (“2007 Plan”) or the stockholder-approved 2014 Stock Incentive Plan (“2014 Plan”). Stockholder approval of the 2014 Plan became effective in September 2014. The 2014 Plan originally provided that the aggregate number of shares of common stock that may be issued pursuant to awards granted under the 2014 Plan may not exceed 450,000 shares (the “Share Reserve”), however in October 2015, the stockholders approved a 1,500,000 increase to the Share Reserve. In addition, the Share Reserve automatically increases on January 1st of each year, for a period of not more than 10 years, beginning on January 1st of the year following the year in which the 2014 Plan became effective and ending on (and including) January 1, 2024, in an amount equal to 4% of the total number of shares of common stock outstanding on December 31st of the preceding calendar year. The Company’s Board of Directors may act prior to January 1st of a given year to provide that there will be no January 1st increase in the Share Reserve for such year or that the increase in the Share Reserve for such year will be a lesser number of shares of common stock than would otherwise occur. On January 1, 2015, the Share Reserve increased by 188,640 shares due to the automatic 4% increase. On January 1, 2016, the Share Reserve increased by 204,943 shares due to the automatic 4% increase. On January 1, 2017, the Share Reserve increased by 204,943 shares due to the automatic 4% increase. On January 1, 2018, the Share Reserve increased by 235,090 shares due to the automatic 4% increase. The Share Reserve is currently 2,783,616 shares for the quarter ended June 30, 2018.

In light of stockholder approval of the 2014 Plan, the Company no longer grants equity awards under the 2007 Plan. As of June 30, 2018, 0 shares of an aggregate total of 407,500 shares were available for future stock-based compensation grants under the 2007 Plan and 987,337 shares of an aggregate total of 2,783,616 shares were available for future stock-based compensation grants under the 2014 Plan.

Semler Scientific, Inc.

Notes to Condensed Financial Statements

Unaudited

(In thousands of U.S. Dollars, except share and per share data)

Aggregate intrinsic value represents the difference between the closing market value as of June 30, 2018 of the underlying common stock and the exercise price of outstanding, in-the-money options. A summary of the Company’s stock option activity and related information for the six months ended June 30, 2018 is as follows:

	Options Outstanding
	Number of Stock Options Outstanding			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (In Years)		Aggregate Intrinsic Value (in thousands)
Balance, January 1, 2018		1,855,138		$	2.69		7.48	$	9,850
Options granted		135,000			8.00
Options exercised		(105,378	)		2.32
Options forfeited/canceled		(6,410	)		3.44
Balance, June 30, 2018		1,878,350		$	3.09		7.23	$	23,216
Exercisable as of June 30, 2018		1,508,900		$	2.77		6.94	$	19,131

The total compensation cost related to unvested stock option awards not yet recognized was $1,184 as of June 30, 2018. The weighted average period over which the total unrecognized compensation cost related to these unvested stock awards will be recognized is 2.22 years. The weighted average fair value of options granted during the six months ended June 30, 2018 and 2017 was $5.97 and $1.52 per share, respectively, or an aggregate grant date fair value of $806 and $269, respectively.

On January 2, 2018 the Compensation Committee of the Company’s Board of Directors granted, and the full Board ratified, an option to acquire an aggregate of 125,000 shares under the 2014 Plan to the Company’s CEO. This option vests 25% on the one-year anniversary of the grant date and monthly thereafter for 36 months, such that the option is vested in full on the four-year anniversary of the grant date. On January 2, 2018 the Company’s Compensation Committee granted, and the full Board ratified, options to each of the then-seated non-employee Directors to acquire 5,000 shares, for an aggregate of 10,000 shares, under the 2014 Plan. These options vest on the one-year anniversary of their grant date. On February 28, 2018 the Compensation Committee of the Company’s Board of Directors accelerated the vesting on stock options issued to consultants such that all unvested shares were vested on that date. This resulted in a one-time expense of $39 during the six months ended June 30, 2018.

Determining the Fair Value of Stock Options

The Company uses the Black-Scholes pricing model to determine the fair value of stock options. The fair value of each option grant is estimated on the date of the grant. The following assumptions for the periods presented were:

	Three months ended June 30,						Six months ended June 30,
	2018			2017			2018			2017
Expected term (in years)		-			5			5			5
Risk-free interest rate		-	%		1.94	%		2.2	%		1.94 – 2.02	%
Expected volatility		-	%		104.0	%		0.99	%		104.0 – 106.2	%
Expected dividend rate		-	%		-	%		-	%		-	%

The assumptions are based on the following for each of the periods presented:

Valuation Method — The Company estimates the fair value of its stock options using the Black-Scholes option pricing model.

Expected Term — The Company estimates the expected term consistent with the simplified method identified by the SEC. The Company elected to use the simplified method because of its limited history of stock option exercise activity and its stock options meet the criteria of the “plain-vanilla” options as defined by the SEC. The simplified method calculates the expected term as the average of the vesting and contractual terms of the award.

Volatility — Because the Company has limited trading history by which to determine the volatility of its own common stock price, the expected volatility being used is derived from the historical stock volatilities of a representative industry peer group of comparable publicly listed companies over a period approximately equal to the expected term of the options.

Semler Scientific, Inc.

Notes to Condensed Financial Statements

Unaudited

(In thousands of U.S. Dollars, except share and per share data)

Risk-free Interest Rate — The risk-free interest rate is based on median U.S. Treasury zero coupon issues with remaining terms similar to the expected term on the options.

Expected Dividend — The Company has never declared or paid any cash dividends and does not plan to pay cash dividends in the foreseeable future, and therefore, used an expected dividend yield of zero in the valuation model.

Forfeiture — Beginning in the first quarter of 2017, the Company implemented ASU 2016-09, and elected to true-up calculations at the time of forfeiture, rather than creating an estimate at the time of option issuance.

The Company has recorded an expense of $138 and $87 as it relates to stock-based compensation for the three months ended June 30, 2018 and 2017, respectively. The Company has recorded an expense of $331 and $165 as it relates to stock-based compensation for the six months ended June 30, 2018 and 2017, respectively:

	Three months ended June 30,				Six months ended June 30
	2018		2017		2018		2017
Cost of Revenue	$	1	$	1	$	1	$	1
Engineering and Product Development		9		12		17		24
Sales and Marketing		22		24		51		45
General and Administrative		106		50		262		95
Total	$	138	$	87	$	331	$	165

10.

Net Income (Loss) Per Share, Basic and Diluted

Basic earnings (loss) per share (“EPS”) represent net income (loss) attributable to common shareholders divided by the weighted average number of common shares outstanding during the measurement period. Diluted EPS represents net income attributable to common shareholders divided by the weighted average number of common shares outstanding during the measurement period while also giving effect to all potentially dilutive common shares that were outstanding during the period using the treasury stock method.

Basic and diluted net EPS is calculated as follows:

	Three months ended June 30,
	2018						2017
	Shares		Net Income		EPS		Shares		Net Loss			EPS
Basic EPS		5,982,711	$	1,453	$	0.24		5,340,234	$	(850	)	$	(0.16	)
Common stock warrants		281,224		-				-		-
Common stock options		1,270,911		-				-		-
Diluted EPS		7,534,846	$	1,453	$	0.19		5,340,234	$	(850	)	$	(0.16	)

	Six months ended June 30,
	2018						2017
	Shares		Net Income		EPS		Shares		Net Loss			EPS
Basic EPS		5,953,818	$	2,159	$	0.36		5,286,179	$	(1,722	)	$	(0.33	)
Common stock warrants		256,916		-				-		-
Common stock options		1,195,010		-				-		-
Diluted EPS		7,403,498	$	2,159	$	0.29		5,286,179	$	(1,722	)	$	(0.33	)

The following weighted average shares outstanding of common stock equivalents were excluded from the computation of diluted net loss per share for the three and six months ended June 30, 2018 and 2017 because including them would have been anti-dilutive:

	Three months ended June 30,				Six months ended June 30,
	2018		2017		2018		2017
Weighted average shares outstanding:
Common stock warrants		-		839,614		-		795,490
Options		135,000		2,040,322		135,000		2,120,936
Total		135,000		2,879,936		135,000		2,916,426

Semler Scientific, Inc.

Notes to Condensed Financial Statements

Unaudited

(In thousands of U.S. Dollars, except share and per share data)

11.

Subsequent Events

None

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion and analysis should be read together with our condensed unaudited financial statements and the related notes appearing elsewhere in this quarterly report on Form 10-Q and with the audited financial statements and notes for the fiscal year ended December 31, 2017, and the information under the headings “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K filed with the SEC on March 8, 2018, or the Annual Report. This discussion contains forward-looking statements reflecting our current expectations that involve risks and uncertainties. See “Cautionary Note Regarding Forward-Looking Statements” for a discussion of the uncertainties, risks and assumptions associated with these statements. Actual results and the timing of events could differ materially from those discussed in our forward-looking statements as a result of many factors, including those set forth under “Risk Factors” in our Annual Report.

Overview

We are an emerging growth company providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. Our mission is to develop, manufacture and market innovative proprietary products and services that assist our customers in evaluating and treating chronic diseases. In 2011, we began commercializing our first patented and U.S. Food and Drug Administration, or FDA, cleared product, which measured arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease, or PAD. In March 2015, we received FDA 510(k) clearance for the next generation version of our product, QuantaFlo™, which we began commercializing in August 2015. We believe our products and services position us to provide valuable information to our customer base, which in turn permits them to better guide patient care.

In the three months ended June 30, 2018, we had total revenues of $5,484,000 and net income of $1,453,000 compared to total revenues of $2,578,000 and a net loss of $850,000 in the same period in 2017. In the six months ended June 30, 2018, we had total revenues of $9,947,000 and net income of $2,159,000 compared to total revenues of $4,633,000 and a net loss of $1,722,000 in the same period in 2017.

Emerging Growth Company Elections

The JOBS Act provides that an emerging growth company, such as our company, can take advantage of an extended transition period for complying with new or revised accounting standards. This allows an emerging growth company to delay the adoption of these accounting standards until they would otherwise apply to private companies. We have elected to avail ourselves of this exemption. As a result, our financial statements may not be comparable to other public companies that comply with public company effective dates. In the future, we may elect to opt out of the extended period for adopting new accounting standards. If we do so, we would need to disclose such decision and it would be irrevocable.

Factors Affecting Future Results

We have not identified any factors that have a recurring effect that are necessary to understand period to period comparisons as appropriate, nor any one-time events that have an effect on the financials. Also, given our relatively limited operating history, we have not yet definitively identified any seasonality.

Results of Operations

Three Months Ended June 30, 2018 Compared to Three Months Ended June 30, 2017

Revenues

We had revenues of $5,484,000 for the three months ended June 30, 2018, an increase of $2,906,000, or 113%, compared to $2,578,000 in the same period in 2017. Our revenues are primarily generated from leasing or per-use fees of our vascular testing products. We recognized revenues of $4,000,000 from leasing of vascular testing products for the quarter ended June 30, 2018, an increase of $1,731,000 compared to $2,269,000 in the same period in 2017. The remainder was from per-use fees and other equipment/supply sales of vascular testing products, which together increased to $1,484,000 in the three months ended June 30, 2018, as compared to $309,000 in the same period in 2017. As a percentage of total revenues, revenues from leasing of vascular testing products were 73% for the three months ended June 30, 2018, compared to 88% in the same period in 2017; whereas revenues from per-use fees and other equipment/supply sales of vascular testing products were 27% for the three months ended June 30, 2018, compared to 12% in the same period in 2017.

For leasing of vascular testing products, we recognize revenues monthly for each unit installed with a customer. The average amount recognized each month per unit of product in the field is affected by the mix of units rented by direct customers or distributors, by price changes and by discounts. The primary reason for the increase in leasing revenues was that the total number of installed units in the field generating monthly leasing revenues grew 57%, and the average amount of revenues recognized per leased unit grew 12%. We believe that growth in the number of monthly invoices is predominately due to our sales and marketing efforts, which added new customers to an established customer base. Growth in the average amount of revenues recognized per leased unit was attributable to changes in the mix of customers leasing the higher-priced QuantaFlo™ vascular testing units instead of its predecessor product, which was lower-priced. Growth in per-use fees was attributable to both our sales and marketing efforts placing new units in the field, as well as increased usage of units previously placed with customers.

Operating expenses

We had total operating expenses of $3,949,000 for the three months ended June 30, 2018, an increase of $817,000, or 26%, compared to $3,132,000 in the same period in 2017. The primary reasons for this increase were overall growth in our business, increased compensation of the sales team and increased headcount of field sales and technical support personnel to service the expanding number of customers. The changes in the various components of our operating expenses are described below.

Cost of revenues

We had cost of revenues of $680,000 for the three months ended June 30, 2018, an increase of $88,000, or 15%, compared to $592,000 in the same period in 2017. The primary reason for this increase was increased costs due to increased sales volume of, placement of and technical support for installations in the field. As a percentage of revenues, cost of revenues decreased to 12% for the three months ended June 30, 2018, as compared to 23% in the same period in 2017. This decrease was primarily due to a greater percentage of new installations being software and sensor only rather than laptop, software and sensor, which means we have lower depreciation per unit per month and lower residual value for retired units. These decreases were partially offset by technical support expense accounted for as cost of revenues rather than as a general and administrative expense, and the greater number of units in the field.

Engineering and product development expense

We had engineering and product development expense of $489,000 for the three months ended June 30, 2018, an increase of $15,000, or 3%, compared to $474,000 in the same period in 2017. The slight increase was primarily due to timing of personnel and other costs associated with our product development and customization efforts.

Sales and marketing expense

We had sales and marketing expense of $1,779,000 for the three months ended June 30, 2018, an increase of $615,000, or 53%, compared to $1,164,000 in the same period in 2017. The increase was primarily due to higher sales compensation and personnel expense in connection with the continued expansion of existing customer orders and marketing activities and increased headcount as compared to the prior year period.

General and administrative expense

We had general and administrative expense of $1,001,000 for the three months ended June 30, 2018, an increase of $99,000, or 11%, compared to $902,000 in the same period in 2017. The increase was primarily due to increased expenses reflective of the growth in our business, such as increased personnel, legal, audit/taxes, stock compensation, uncollectable accounts and other expenses, partially offset by lower board of director fees, insurance, and technical support expenses.

Other expense

We had other expense of $82,000 for the three months ended June 30, 2018, a decrease of $214,000, or 72%, compared to $296,000 in the same period in 2017. The decrease was primarily due to inclusion in 2017 of a loss on the extinguishment of loans payable of $179,000, which arose due to the May 2017 amendment of our loans from Mr. Chang, which was treated as an extinguishment for accounting purposes. Other expense also decreased as a result of a decrease in interest of $34,000 associated with retirement of notes payable and decreased other expenses of $1,000.

Net income

For the foregoing reasons, we had net income of $1,453,000, or $0.24 per basic share and $0.19 per diluted share, for the three months ended June 30, 2018, an increase of $2,303,000 compared to a net loss of $850,000, or $0.16 per share basic and diluted share, for the same period in 2017.

Six Months Ended June 30, 2018 Compared to Six Months Ended June 30, 2017

Revenues

We had revenues of $9,947,000 for the six months ended June 30, 2018, an increase of $5,314,000, or 115%, compared to $4,633,000 in the same period in 2017. Our revenues are primarily generated from leasing or per-use fees of our vascular testing products. We recognized revenues of $7,716,000 from leasing of vascular testing products for the first half of 2018, an increase of $3,470,000 compared to $4,246,000 in the same period in 2017. The remainder was from per-use fees and other equipment/supply sales of vascular testing products, which increased to $2,231,000 in the six months ended June 30, 2018, as compared to $387,000 in the same period in 2017. As a percentage of total revenues, revenues from leasing of vascular testing products were 78% for the six months ended June 30, 2018, compared to 92% in the same period in 2017; whereas revenues from per-use fees and other equipment/supply sales of vascular testing products were 22% for the six months ended June 30, 2018, compared to 8% in the same period in 2017.

For leasing of vascular testing products, we recognize revenues monthly for each unit installed with a customer. The average amount recognized each month per unit of product in the field is affected by the mix of units rented by direct customers or distributors, by price changes and by discounts. The primary reason for the increase in leasing revenues was that the total number of installed units in the field generating monthly leasing revenues grew 60%, and the average amount of revenues recognized per leased unit grew 14%. We believe that growth in the number of monthly invoices is predominately due to our sales and marketing efforts, which added new customers to an established customer base. Growth in the average amount of revenues recognized per unit was attributable to changes in the mix of customers leasing the higher-priced QuantaFlo™ vascular testing units instead of its predecessor product, which was lower-priced. Growth in per-use fees was attributable to both our sales and marketing efforts placing new units in the field, as well as increased usage of units previously placed with customers.

Operating expenses

We had total operating expenses of $7,599,000 for the six months ended June 30, 2018, an increase of $1,662,000, or 28%, compared to $5,937,000 in the same period in 2017. The primary reason for this was overall growth in our business, increased compensation of the sales team and increased headcount of field sales and technical support personnel to service the expanding number of customers. The changes in the various components of our operating expenses are described below.

Cost of revenues

We had cost of revenues of $1,384,000 for the six months ended June 30, 2018, an increase of $253,000, or 22%, from $1,131,000 for the same period in the previous year. The primary reason for this increase was increased costs due to increased sales volume of, placement of and technical support for installations in the field. As a percentage of revenues, cost of revenues decreased to 14% in the six months ended June 30, 2018, as compared to 24% in the same period in 2017. This decrease was primarily due to a greater percentage of new installations being software and senor only rather than laptop, software and sensor, which means we have lower depreciation per unit per month and lower residual value for retired units. These decreases were partially offset by technical support expense accounted for as cost of revenue rather than as a general and administrative expense, and the greater number of units in the field.

Engineering and product development expense

We had engineering and product development expense of $856,000 for the six months ended June 30, 2018, a decrease of $57,000, or 6%, compared to $913,000 in the same period in 2017. The slight decrease reflects decreased expenses associated with our product development and customization efforts, offset by increased costs associated with personnel involved therewith.

Sales and marketing expense

We had sales and marketing expense of $3,484,000 for the six months ended June 30, 2018, an increase of $1,331,000, or 62%, compared to $2,153,000 in the same period in 2017. The increase was primarily due to higher sales compensation and personnel expense in connection with the continued expansion of existing customer orders and marketing activities and increased headcount as compared to the prior year period.

General and administrative expense

We had general and administrative expense of $1,875,000 for the six months ended June 30, 2018, an increase of $135,000, or 8%, compared to $1,740,000 in the same period in 2017. The increase was primarily due to increased expenses reflective of the growth in our business, such as increased personnel, stock compensation, uncollectable accounts and other expenses, partially offset by lower board of director fees, legal, audit/taxes, insurance, and technical support expenses.

Other expense

We had other expense of $189,000 for the six months ended June 30, 2018, a decrease of $229,000, or 55%, compared to $418,000 in the same period in 2017. The decrease was primarily due to inclusion in 2017 of a loss on the extinguishment of loans payable of $179,000, which arose due to the May 2017 amendment of our loans from Mr. Chang, which was treated as an extinguishment for accounting purposes. Other expense also decreased due to decreased interest expense of $43,000 associated with retirement of notes payable, as well as decreased income tax and other expenses of $6,000.

Net income

For the foregoing reasons, we had net income of $2,159,000, or $0.36 per basic share and $0.29 per diluted share, for the six months ended June 30, 2018, an increase of $3,881,000 compared to a net loss of $1,722,000, or $0.33 per basic and diluted share, for the same period in 2017.

Liquidity and Capital Resources

We had cash of $2,009,000 at June 30, 2018 compared to $1,457,000 at December 31, 2017, and total current liabilities of $5,078,000 at June 30, 2018 compared to $5,140,000 at December 31, 2017. As of June 30, 2018 we had negative working capital of approximately $1,003,000 as compared to $2,257,000 at December 31, 2017. During the six months ended June 30, 2018, we reduced total liabilities by $1,725,000 as compared to the year ended December 31, 2017, as we retired debts and reduced accounts payable, among other items.

Prior to the three months ended December 31, 2017, we had incurred losses since inception as a result of costs and expenses related to our marketing and other promotional activities, and continued research and development of our products and services. Our principal sources of cash have included the issuance of equity, including our February 2014 initial public offering of common stock, and private placement offerings of common stock, borrowings under loan agreements, the issuance of promissory notes, and revenues from our vascular testing product. There is no guarantee that we will continue to generate sufficient cash from operations to remain profitable or that we will be able to raise additional financing from other sources. For these reasons, our independent registered public accountants’ report for the year ended December 31, 2017 includes an explanatory paragraph that expresses substantial doubt about our ability to continue as a “going concern.”

Although we do not have any current capital commitments, we expect that we may increase our expenditures to continue our efforts to grow our business and commercialize our products and services. Accordingly, we currently expect to make additional expenditures in both sales and marketing, and invest in our corporate infrastructure. We also expect to invest in our research and development efforts. We do not have any definitive plans as to the exact amounts or particular uses at this time, and the exact amounts and timing of any expenditure may vary significantly from our current intentions. If we are unable to generate sufficient cash from operations, we may need to obtain additional financing. There is no assurance that additional financing will be available when needed or that management will be able to obtain financing on acceptable terms should the company not sustain a profitable business with positive operating cash flow. If we are unable to raise sufficient additional funds when and if necessary, we may need to curtail making additional expenditures and could be required to scale back our business plans, or make other changes until sufficient additional capital is raised to support further operations. There can be no assurance that such a plan will be successful.

Operating activities

We generated $1,508,000 of net cash from operating activities for the six months ended June 30, 2018 compared to using $70,000 of net cash in operating activities for the same period in 2017. The improvement was primarily due to having net income instead of a net loss, as well as increases in total non-cash adjustments, partially offset by changes in operating assets and liabilities that used cash, primarily trade accounts receivable, accrued expenses, accounts payable, and prepaid expenses.

Investing activities

We used $243,000 of net cash in investing activities for the six months ended June 30, 2018, which reflects purchases of assets for lease of $138,000 and fixed asset purchases of $105,000 to support our growing business.

We used $603,000 of net cash in investing activities for the six months ended June 30, 2017, which reflects purchases of assets for lease of $591,000 and fixed asset purchases of $12,000 to support our growing business.

Financing activities

We used $713,000 in net cash in financing activities during the six months ended June 30, 2018, reflecting the payment of loans payable of $1,022,000, partially offset by proceeds from exercise of warrants and stock options of $309,000.

We generated $547,000 in net cash from financing activities during the six months ended June 30, 2017 due to proceeds from sales of common stock of $553,000 ($78,000 of which was related to proceeds from exercise of stock options), and proceeds from loans payable of $63,000, partially offset by payments of loans payable of $69,000.

Description of Indebtedness

In January 2016, we borrowed an aggregate of $1.5 million from the Chang Family Trust, one of our significant stockholders and the family trust of our former director, William H.C. Chang, pursuant to two separate 2-year promissory notes. We amended the terms of the notes in May 2017 to extend the maturity date by one year to January 2019. The notes bear simple interest ($1.0 million at a rate of 10% per annum, and $0.5 million at 5% per annum) and mature January 21, 2019, as amended, with all interest payable at maturity. We may prepay the notes at any time prior to maturity without penalty. The notes must be repaid prior to maturity in the event of default, and we agreed not to incur additional indebtedness in excess of $50,000 without the lender’s prior consent, which is not to be unreasonably withheld. In connection therewith, we issued the Chang Family Trust two-year warrants to purchase an aggregate of 228,572 shares of our common stock at an exercise price of $1.75 per share. We amended the warrants in May 2017 to remove the requirement that stockholder approval be obtained if such exercise would result in beneficial ownership of more than 19.99%. The Chang Family Trust exercised these warrants for an aggregate 228,572 shares of our common stock in December 2017. In connection with the May 2017 amendment of such notes and warrants, we issued the Chang Family Trust warrants to acquire an aggregate of 134,616 shares of our common stock at $2.60 per share, which warrants expire January 21, 2022, three years after the maturity date of the notes, as amended.

In April 2016, we borrowed an aggregate of $160,000 from an accredited investor, pursuant to a two-year promissory note. The note bears simple interest at a rate of 10% per annum and matures in two years, with all principal and accrued but unpaid interest payable at maturity. The notes may be prepaid at any time prior to maturity without penalty. The notes must be repaid prior to maturity in the event of default. In connection therewith, we issued a two-year warrant to purchase an aggregate of 18,162 shares of our common stock at an exercise price of $1.85 per share, which warrants were exercised in full in December 2017. Principal and interest on this note were paid in full in April 2018.

In May 2016, we borrowed an aggregate of $80,000 from an accredited investor, pursuant to a two-year promissory note. The note bears simple interest at a rate of 10% per annum and matures in two years, with all principal and accrued but unpaid interest payable at maturity. The notes may be prepaid at any time prior to maturity without penalty. The notes must be repaid prior to maturity in the event of default. In connection therewith, we issued a two-year warrant to purchase an aggregate of 9,081 shares of our common stock at an exercise price of $1.85 per share. The warrants may not be exercised, however, absent receipt of stockholder approval, if after such exercise the holder would be the beneficial owner of more than 4.99% of our common stock. The warrants were partially exercised in December 2017 for an aggregate 7,323 shares of our common stock with the remainder being exercised in March 2018. Principal and interest on this note were paid in full during the quarter ended June 30, 2018.

In November 2016, we borrowed an aggregate of $250,000 from an accredited investor, pursuant to a two-year promissory note. The note bears a simple interest rate of 10% per annum and matures in two years, with all principal and accrued but unpaid interest payable at maturity. The notes may be prepaid at any time prior to maturity without penalty. The notes must be repaid prior to maturity in the event of default. In connection therewith, we issued a two-year warrant to purchase an aggregate of 28,378 shares of our common stock at an exercise price of $1.85 per share. The warrants, which were not able to be exercised, however, absent receipt of stockholder approval, if after such exercise the holder would be the beneficial owner of more than 9.99% of our common stock, were exercised in full in January 2018.

In addition to the above, we have also entered into other debt financing arrangements, including equipment and software financing arrangements. See Note 8 to our financial statements appearing elsewhere in this interim report on Form 10-Q for description of our indebtedness.

Off-Balance Sheet Arrangements

As of each of June 30, 2018 and December 31, 2017, we had no off-balance sheet arrangements.

Commitments and Contingencies

As of each of June 30, 2018 and December 31, 2017, other than employment/consulting agreements with key executive officers and our facilities lease obligation, we had no material commitments other than the liabilities reflected in our financial statements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Not applicable.

Item 4. Controls and Procedures.

Disclosure Controls and Procedures

In evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our management, with the participation of our chief executive officer and our vice president, finance, evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this quarterly report on Form 10-Q. Based on that evaluation, our chief executive officer and our vice president, finance concluded that our disclosure controls and procedures were not effective, at the reasonable assurance level, as of the end of the period covered by this report to ensure that information we are required to disclose in reports that we file or submit under the Securities Exchange Act of 1934 (1) is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (2) is accumulated and communicated to management, including our chief executive officer and our vice president, finance as appropriate to allow timely decisions regarding required disclosure, due to the existence of the material weaknesses in our internal control over financial reporting.

Changes in Internal Control over Financial Reporting

In the second quarter of 2018, in an effort to remediate prior material weaknesses, we introduced new internal controls and continued to assess effectiveness of controls for matters related to identifying and analyzing related party transactions and a lack of technical accounting competence, which efforts we commenced in the first quarter of 2018. Other than these remedial changes, there have been no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting during our second quarter ended June 30, 2018.

PART II — OTHER INFORMATION

Item 1. Legal Proceedings.

Not applicable.

Item 1A. Risk Factors.

Not applicable.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

In June 2018 we issued an aggregate of 7,800 shares of our common stock upon cashless exercise of warrants to acquire an aggregate 32,175 shares that were issued to the representatives in connection with our February 2014 initial public offering. We relied upon the exemption provided in Section 4(a)(2) of the Securities Act to issue such shares upon exercise of the warrants.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

Not applicable.

Item 6. Exhibits.

Exh. No.		Exhibit Name
31.1		Rule 13a-14(a) Certification of Principal Executive Officer of Registrant
31.2		Rule 13a-14(a) Certification of Principal Financial Officer of Registrant
32.1		Section 1350 Certification

101.INS		XBRL Instance Document
101.SCH		XBRL Taxonomy Extension Schema
101.CAL		XBRL Taxonomy Extension Calculation Linkbase
101.DEF		XBRL Taxonomy Extension Definition Linkbase
101.LAB		XBRL Taxonomy Extension Label Linkbase
101.PRE		XBRL Taxonomy Extension Presentation Linkbase

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

August 3, 2018	SEMLER SCIENTIFIC, INC.

	By:	/s/ Douglas Murphy-Chutorian, M.D.
		Douglas Murphy-Chutorian, M.D.
		Chief Executive Officer

	By:	/s/ Daniel Conger
		Daniel Conger
		Vice President, Finance
		Principal Accounting Officer

EX-31.1 2 tv499575_ex31-1.htm EXHIBIT 31.1

Exhibit 31.1

CERTIFICATIONS

I, Douglas Murphy-Chutorian, M.D., certify that:

1. I have reviewed this quarterly report on Form 10-Q of Semler Scientific, Inc., a Delaware corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated: August 3, 2018
	/s/ Douglas Murphy-Chutorian, M.D.
	Douglas Murphy-Chutorian, M.D.
	Chief Executive Officer

EX-31.2 3 tv499575_ex31-2.htm EXHIBIT 31.2

Exhibit 31.2

I, Daniel Conger, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Semler Scientific, Inc., a Delaware corporation;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated: August 3, 2018

	/s/ Daniel Conger
	Daniel Conger, Vice President, Finance
	(Principal Accounting Officer)

EX-32.1 4 tv499575_ex32-1.htm EXHIBIT 32.1

Exhibit 32.1

SECTION 1350 CERTIFICATION

Each of the undersigned, Douglas Murphy-Chutorian, M.D., Chief Executive Officer of Semler Scientific, Inc., a Delaware corporation (the “Company”), and Daniel Conger, Vice-President, Finance of the Company, does hereby certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge (1) the quarterly report on Form 10-Q of the Company for the period ended June 30, 2018, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

	/s/ Douglas Murphy-Chutorian, M.D.
	Name: Douglas Murphy-Chutorian, M.D.
	Title: Chief Executive Officer
	(Principal Executive Officer)
	Dated: August 3, 2018

	/s/ Daniel Conger
	Name: Daniel Conger
	Title: Vice President, Finance
	(Principal Accounting Officer)
	Dated: August 3, 2018

This certification accompanies and is being “furnished” with this Report, shall not be deemed “filed” by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Report, irrespective of any general incorporation language contained in such filing. A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-101.INS 5 smlr-20180630.xml XBRL INSTANCE DOCUMENT 0001554859 smlr:LeaseAgreementMember 2014-09-23 0001554859 smlr:StockIncentivePlan2014Member us-gaap:EmployeeStockOptionMember 2015-01-01 2015-01-31 0001554859 smlr:SubLeaseAgreementMember 2015-07-15 0001554859 smlr:StockIncentivePlan2014Member us-gaap:EmployeeStockOptionMember 2015-10-01 2015-10-31 0001554859 us-gaap:UnsecuredDebtMember smlr:LoanAgreementMember smlr:ChangFamilyTrustMember 2016-01-15 0001554859 us-gaap:UnsecuredDebtMember smlr:LoanAgreementMember smlr:ChangFamilyTrustMember 2016-01-01 2016-01-15 0001554859 us-gaap:UnsecuredDebtMember smlr:LoanAgreementMember smlr:ChangFamilyTrustMember 2016-01-21 0001554859 us-gaap:UnsecuredDebtMember smlr:LoanAgreementMember smlr:ChangFamilyTrustMember 2016-01-01 2016-01-21 0001554859 smlr:StockIncentivePlan2014Member us-gaap:EmployeeStockOptionMember 2016-01-01 2016-01-31 0001554859 us-gaap:UnsecuredDebtMember smlr:LoanAgreementMember us-gaap:InvestorMember 2016-03-31 0001554859 us-gaap:UnsecuredDebtMember smlr:LoanAgreementMember us-gaap:InvestorMember 2016-03-01 2016-03-31 0001554859 us-gaap:UnsecuredDebtMember smlr:LoanAgreementMember us-gaap:InvestorMember 2016-04-05 0001554859 us-gaap:UnsecuredDebtMember smlr:LoanAgreementMember us-gaap:InvestorMember 2016-04-01 2016-04-05 0001554859 us-gaap:UnsecuredDebtMember smlr:LoanAgreementMember us-gaap:InvestorMember 2016-05-20 0001554859 us-gaap:UnsecuredDebtMember smlr:LoanAgreementMember us-gaap:InvestorMember 2016-05-01 2016-05-20 0001554859 smlr:SoftwareLicenseFinancingAgreementMember smlr:AscentiumCapitalLlcMember 2016-07-08 0001554859 smlr:SoftwareLicenseFinancingAgreementMember smlr:AscentiumCapitalLlcMember 2016-07-01 2016-07-08 0001554859 smlr:SecuredEquipmentFinancingAgreementMember smlr:RoyalBankAmericaLeasingLPMember 2016-07-11 0001554859 smlr:SecuredEquipmentFinancingAgreementMember smlr:RoyalBankAmericaLeasingLPMember us-gaap:DebtInstrumentRedemptionPeriodOneMember 2016-07-11 0001554859 smlr:SecuredEquipmentFinancingAgreementMember smlr:RoyalBankAmericaLeasingLPMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember 2016-07-11 0001554859 smlr:SecuredEquipmentFinancingAgreementMember smlr:RoyalBankAmericaLeasingLPMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember 2016-07-11 0001554859 smlr:SecuredEquipmentFinancingAgreementMember smlr:RoyalBankAmericaLeasingLPMember 2016-07-01 2016-07-11 0001554859 smlr:SecuredEquipmentFinancingAgreementMember smlr:AscentiumCapitalLlcMember 2016-10-02 0001554859 smlr:SecuredEquipmentFinancingAgreementMember smlr:AscentiumCapitalLlcMember 2016-10-01 2016-10-02 0001554859 us-gaap:UnsecuredDebtMember smlr:LoanAgreementMember smlr:GlenJKrevlinMember 2016-11-21 0001554859 us-gaap:UnsecuredDebtMember smlr:LoanAgreementMember smlr:GlenJKrevlinMember 2016-11-01 2016-11-21 0001554859 smlr:StockIncentivePlan2014Member us-gaap:EmployeeStockOptionMember 2017-01-01 2017-01-31 0001554859 smlr:SoftwareLicenseFinancingAgreementMember smlr:AscentiumCapitalLlcMember 2017-04-01 0001554859 smlr:SoftwareLicenseFinancingAgreementMember smlr:AscentiumCapitalLlcMember 2017-03-29 2017-04-01 0001554859 us-gaap:UnsecuredDebtMember smlr:AmendedLoanAgreementMember smlr:ChangFamilyTrustMember 2017-05-02 0001554859 us-gaap:UnsecuredDebtMember smlr:AmendedLoanAgreementMember smlr:ChangFamilyTrustMember 2017-05-01 2017-05-02 0001554859 2017-04-02 2017-06-30 0001554859 us-gaap:CostOfSalesMember 2017-04-02 2017-06-30 0001554859 smlr:EngineeringAndProductDevelopmentMember 2017-04-02 2017-06-30 0001554859 us-gaap:SellingAndMarketingExpenseMember 2017-04-02 2017-06-30 0001554859 us-gaap:GeneralAndAdministrativeExpenseMember 2017-04-02 2017-06-30 0001554859 us-gaap:WarrantMember 2017-04-02 2017-06-30 0001554859 us-gaap:EmployeeStockOptionMember 2017-04-02 2017-06-30 0001554859 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2017-04-02 2017-06-30 0001554859 smlr:CustomerOneConcentrationRiskMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2017-04-02 2017-06-30 0001554859 us-gaap:MeasurementInputExpectedTermMember 2017-04-02 2017-06-30 0001554859 us-gaap:MeasurementInputRiskFreeInterestRateMember 2017-04-02 2017-06-30 0001554859 us-gaap:MeasurementInputPriceVolatilityMember 2017-04-02 2017-06-30 0001554859 us-gaap:MeasurementInputExpectedDividendRateMember 2017-04-02 2017-06-30 0001554859 2017-01-01 2017-06-30 0001554859 us-gaap:CostOfSalesMember 2017-01-01 2017-06-30 0001554859 smlr:EngineeringAndProductDevelopmentMember 2017-01-01 2017-06-30 0001554859 us-gaap:SellingAndMarketingExpenseMember 2017-01-01 2017-06-30 0001554859 us-gaap:GeneralAndAdministrativeExpenseMember 2017-01-01 2017-06-30 0001554859 srt:MinimumMember 2017-01-01 2017-06-30 0001554859 srt:MaximumMember 2017-01-01 2017-06-30 0001554859 us-gaap:WarrantMember 2017-01-01 2017-06-30 0001554859 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-06-30 0001554859 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2017-01-01 2017-06-30 0001554859 smlr:CustomerOneConcentrationRiskMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2017-01-01 2017-06-30 0001554859 us-gaap:MeasurementInputExpectedTermMember 2017-01-01 2017-06-30 0001554859 us-gaap:MeasurementInputRiskFreeInterestRateMember 2017-01-01 2017-06-30 0001554859 us-gaap:MeasurementInputPriceVolatilityMember 2017-01-01 2017-06-30 0001554859 us-gaap:MeasurementInputExpectedDividendRateMember 2017-01-01 2017-06-30 0001554859 2017-01-01 2017-12-31 0001554859 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2017-01-01 2017-12-31 0001554859 smlr:CustomerOneConcentrationRiskMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2017-01-01 2017-12-31 0001554859 smlr:CustomerTwoConcentrationRiskMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2017-01-01 2017-12-31 0001554859 2017-12-31 0001554859 smlr:ChangFamilyTrustMember 2017-12-31 0001554859 smlr:ChangFamilyTrustOneMember 2017-12-31 0001554859 us-gaap:InvestorMember 2017-12-31 0001554859 smlr:InvestorOneMember 2017-12-31 0001554859 smlr:InvestorTwoMember 2017-12-31 0001554859 smlr:AscentiumCapitalLlcMember 2017-12-31 0001554859 smlr:AscentiumCapitalLlcOneMember 2017-12-31 0001554859 smlr:AscentiumCapitalLlcThreeMember 2017-12-31 0001554859 smlr:RoyalBankAmericaLeasingLPMember 2017-12-31 0001554859 smlr:GlenJKrevlinMember 2017-12-31 0001554859 smlr:StockIncentivePlan2014Member us-gaap:EmployeeStockOptionMember smlr:NonEmployeeDirectorsMember 2018-01-02 0001554859 smlr:StockIncentivePlan2014Member us-gaap:EmployeeStockOptionMember us-gaap:BoardOfDirectorsChairmanMember 2018-01-02 0001554859 smlr:StockIncentivePlan2014Member us-gaap:EmployeeStockOptionMember 2018-01-01 2018-01-31 0001554859 2018-04-01 2018-06-30 0001554859 us-gaap:CostOfSalesMember 2018-04-01 2018-06-30 0001554859 smlr:EngineeringAndProductDevelopmentMember 2018-04-01 2018-06-30 0001554859 us-gaap:SellingAndMarketingExpenseMember 2018-04-01 2018-06-30 0001554859 us-gaap:GeneralAndAdministrativeExpenseMember 2018-04-01 2018-06-30 0001554859 us-gaap:WarrantMember 2018-04-01 2018-06-30 0001554859 us-gaap:EmployeeStockOptionMember 2018-04-01 2018-06-30 0001554859 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2018-04-01 2018-06-30 0001554859 smlr:CustomerOneConcentrationRiskMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2018-04-01 2018-06-30 0001554859 smlr:CustomerTwoConcentrationRiskMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2018-04-01 2018-06-30 0001554859 us-gaap:MeasurementInputRiskFreeInterestRateMember 2018-04-01 2018-06-30 0001554859 us-gaap:MeasurementInputPriceVolatilityMember 2018-04-01 2018-06-30 0001554859 us-gaap:MeasurementInputExpectedDividendRateMember 2018-04-01 2018-06-30 0001554859 2018-01-01 2018-06-30 0001554859 us-gaap:CostOfSalesMember 2018-01-01 2018-06-30 0001554859 smlr:EngineeringAndProductDevelopmentMember 2018-01-01 2018-06-30 0001554859 us-gaap:SellingAndMarketingExpenseMember 2018-01-01 2018-06-30 0001554859 us-gaap:GeneralAndAdministrativeExpenseMember 2018-01-01 2018-06-30 0001554859 us-gaap:WarrantMember 2018-01-01 2018-06-30 0001554859 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-06-30 0001554859 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2018-01-01 2018-06-30 0001554859 smlr:CustomerOneConcentrationRiskMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2018-01-01 2018-06-30 0001554859 smlr:CustomerTwoConcentrationRiskMember us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2018-01-01 2018-06-30 0001554859 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2018-01-01 2018-06-30 0001554859 smlr:CustomerOneConcentrationRiskMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2018-01-01 2018-06-30 0001554859 smlr:CustomerTwoConcentrationRiskMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2018-01-01 2018-06-30 0001554859 smlr:LeaseTermFromFebruary2015ToJanuary2016Member smlr:LeaseAgreementMember 2018-01-01 2018-06-30 0001554859 smlr:LeaseTermFromFebruary2016ToJanuary2017Member smlr:LeaseAgreementMember 2018-01-01 2018-06-30 0001554859 smlr:LeaseTermFromFebruary2017ToJanuary2018Member smlr:LeaseAgreementMember 2018-01-01 2018-06-30 0001554859 smlr:LeaseTermFromAugust2015ToJuly2016Member smlr:SubLeaseAgreementMember 2018-01-01 2018-06-30 0001554859 smlr:LeaseTermFromAugust2016ToJuly2017Member smlr:SubLeaseAgreementMember 2018-01-01 2018-06-30 0001554859 smlr:LeaseTermFromAugust2017ToJuly2018Member smlr:SubLeaseAgreementMember 2018-01-01 2018-06-30 0001554859 us-gaap:MeasurementInputRiskFreeInterestRateMember 2018-01-01 2018-06-30 0001554859 us-gaap:MeasurementInputPriceVolatilityMember 2018-01-01 2018-06-30 0001554859 us-gaap:MeasurementInputExpectedDividendRateMember 2018-01-01 2018-06-30 0001554859 2018-06-30 0001554859 smlr:StockIncentivePlan2014Member us-gaap:EmployeeStockOptionMember 2018-06-30 0001554859 smlr:ChangFamilyTrustMember 2018-06-30 0001554859 smlr:ChangFamilyTrustOneMember 2018-06-30 0001554859 us-gaap:InvestorMember 2018-06-30 0001554859 smlr:InvestorOneMember 2018-06-30 0001554859 smlr:InvestorTwoMember 2018-06-30 0001554859 smlr:AscentiumCapitalLlcMember 2018-06-30 0001554859 smlr:AscentiumCapitalLlcOneMember 2018-06-30 0001554859 smlr:AscentiumCapitalLlcThreeMember 2018-06-30 0001554859 smlr:RoyalBankAmericaLeasingLPMember 2018-06-30 0001554859 smlr:GlenJKrevlinMember 2018-06-30 0001554859 smlr:StockIncentivePlan2014Member 2018-06-30 0001554859 smlr:KeyPersonStockOptionPlan2007Member 2018-06-30 0001554859 2018-07-31 0001554859 2016-12-31 0001554859 2017-06-30 xbrli:shares iso4217:USD iso4217:USDxbrli:shares xbrli:pure smlr:Customer Semler Scientific, Inc. 0001554859 smlr --12-31 Smaller Reporting Company 6035496 10-Q 2018-06-30 false 2018 Q2

2578000

4633000

5484000

9947000

592000

1131000

680000

1384000

474000

913000

489000

856000

1164000

2153000

1779000

3484000

902000

1740000

1001000

1875000

3132000

5937000

3949000

7599000

-554000

-1304000

1535000

2348000

72000

145000

9000

56000

43000

86000

72000

131000

2000

8000

1000

2000

-296000

-418000

-82000

-189000

-850000

-1722000

1453000

2159000

-0.16

-0.33

0.24

0.36

-0.16

-0.33

0.19

0.29

5340234

5286179

5982711

5953818

5340234

5286179

7534846

7403498

1457000

2009000

622000

496000

1315000

1850000

111000

216000

2883000

4075000

1147000

975000

193000

247000

15000

4238000

5312000

488000

185000

2670000

2256000

531000

535000

168000

28000

41000

1018000

44000

237000

2017000

5140000

5078000

13000

12000

26000

6000

1642000

1681000

18000

6000

23843000

24484000

-26432000

-24274000

-2583000

216000

4238000

5312000

35000

9000

13000 6000

0.001

50000000

5902244

6048397

5877244

6023397

25000

28000

80000

4000

16000

44000

135000

267000

249000

-55000

-142000

-38000

-107000

5000

20000

165000

331000

13000

535000

7000

105000

96000

-303000

505000

-570000

189000

4000

12000

105000

591000

138000

475000

64000

78000

245000

69000

1022000

-126000

552000

<table style="font: 10pt/normal 'times new roman', times, serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; font-size-adjust: none; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="text-align: justify; vertical-align: top;"> <td style="width: 0px;"></td> <td style="width: 0.5in; text-align: left;"><b>9.</b></td> <td style="text-align: justify;"><b>Stock Option Plan</b></td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; text-indent: 0.5in; font-size-adjust: none; font-stretch: normal;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; text-indent: 0.5in; font-size-adjust: none; font-stretch: normal;">The Company’s stock-based compensation program is designed to attract and retain employees while also aligning employees' interests with the interests of its stockholders. Stock options have been granted to employees under the stockholder-approved 2007 Key Person Stock Option Plan (“2007 Plan”) or the stockholder-approved 2014 Stock Incentive Plan (“2014 Plan”). Stockholder approval of the 2014 Plan became effective in September 2014. The 2014 Plan originally provided that the aggregate number of shares of common stock that may be issued pursuant to awards granted under the 2014 Plan may not exceed 450,000 shares (the “Share Reserve”), however in October 2015, the stockholders approved a 1,500,000 increase to the Share Reserve. In addition, the Share Reserve automatically increases on January 1st of each year, for a period of not more than 10 years, beginning on January 1st of the year following the year in which the 2014 Plan became effective and ending on (and including) January 1, 2024, in an amount equal to 4% of the total number of shares of common stock outstanding on December 31st of the preceding calendar year. The Company’s Board of Directors may act prior to January 1st of a given year to provide that there will be no January 1st increase in the Share Reserve for such year or that the increase in the Share Reserve for such year will be a lesser number of shares of common stock than would otherwise occur. On January 1, 2015, the Share Reserve increased by 188,640 shares due to the automatic 4% increase. On January 1, 2016, the Share Reserve increased by 204,943 shares due to the automatic 4% increase. On January 1, 2017, the Share Reserve increased by 204,943 shares due to the automatic 4% increase. On January 1, 2018, the Share Reserve increased by 235,090 shares due to the automatic 4% increase. The Share Reserve is currently 2,783,616 shares for the quarter ended June 30, 2018.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; text-indent: 0.5in; font-size-adjust: none; font-stretch: normal;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; text-indent: 0.5in; font-size-adjust: none; font-stretch: normal;">In light of stockholder approval of the 2014 Plan, the Company no longer grants equity awards under the 2007 Plan. As of June 30, 2018, 0 shares of an aggregate total of 407,500 shares were available for future stock-based compensation grants under the 2007 Plan and 987,337 shares of an aggregate total of 2,783,616 shares were available for future stock-based compensation grants under the 2014 Plan.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; font-size-adjust: none; font-stretch: normal;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; text-indent: 0.5in; font-size-adjust: none; font-stretch: normal;">Aggregate intrinsic value represents the difference between the closing market value as of June 30, 2018 of the underlying common stock and the exercise price of outstanding, in-the-money options. A summary of the Company’s stock option activity and related information for the six months ended June 30, 2018 is as follows:</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; text-indent: 0.5in; font-size-adjust: none; font-stretch: normal;"> </p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 100%; border-collapse: collapse; font-size-adjust: none; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="14" nowrap="nowrap">Options Outstanding</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">Number of<br />Stock Options<br />Outstanding</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">Weighted<br />Average<br />Exercise Price</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">Weighted<br />Average<br />Remaining<br />Contractual<br />Term (In Years)</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">Aggregate<br />Intrinsic Value<br /> (in thousands)</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 753px; font-weight: bold;">Balance, January 1, 2018</td> <td style="width: 16px; font-weight: bold;"> </td> <td style="width: 16px; text-align: left; font-weight: bold;"> </td> <td style="width: 157px; text-align: right; font-weight: bold;">1,855,138</td> <td style="width: 16px; text-align: left; font-weight: bold;"> </td> <td style="width: 16px; font-weight: bold;"> </td> <td style="width: 16px; text-align: left; font-weight: bold;">$</td> <td style="width: 157px; text-align: right; font-weight: bold;">2.69</td> <td style="width: 16px; text-align: left; font-weight: bold;"> </td> <td style="width: 16px; font-weight: bold;"> </td> <td style="width: 16px; text-align: left; font-weight: bold;"> </td> <td style="width: 156px; text-align: right; font-weight: bold;">7.48</td> <td style="width: 15px; text-align: left; font-weight: bold;"> </td> <td style="width: 15px; font-weight: bold;"> </td> <td style="width: 15px; text-align: left; font-weight: bold;">$</td> <td style="width: 156px; text-align: right; font-weight: bold;">9,850</td> <td style="width: 15px; text-align: left; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Options granted</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">135,000</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">8.00</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left;">Options exercised</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">(105,378</td> <td style="text-align: left;">)</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">2.32</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Options forfeited/canceled</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">(6,410</td> <td style="text-align: left;">)</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">3.44</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="font-weight: bold;">Balance, June 30, 2018</td> <td style="font-weight: bold;"> </td> <td style="text-align: left; font-weight: bold;"> </td> <td style="text-align: right; font-weight: bold;">1,878,350</td> <td style="text-align: left; font-weight: bold;"> </td> <td style="font-weight: bold;"> </td> <td style="text-align: left; font-weight: bold;">$</td> <td style="text-align: right; font-weight: bold;">3.09</td> <td style="text-align: left; font-weight: bold;"> </td> <td style="font-weight: bold;"> </td> <td style="text-align: left; font-weight: bold;"> </td> <td style="text-align: right; font-weight: bold;">7.23</td> <td style="text-align: left; font-weight: bold;"> </td> <td style="font-weight: bold;"> </td> <td style="text-align: left; font-weight: bold;">$</td> <td style="text-align: right; font-weight: bold;">23,216</td> <td style="text-align: left; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="font-weight: bold;">Exercisable as of June 30, 2018</td> <td style="font-weight: bold;"> </td> <td style="text-align: left; font-weight: bold;"> </td> <td style="text-align: right; font-weight: bold;">1,508,900</td> <td style="text-align: left; font-weight: bold;"> </td> <td style="font-weight: bold;"> </td> <td style="text-align: left; font-weight: bold;">$</td> <td style="text-align: right; font-weight: bold;">2.77</td> <td style="text-align: left; font-weight: bold;"> </td> <td style="font-weight: bold;"> </td> <td style="text-align: left; font-weight: bold;"> </td> <td style="text-align: right; font-weight: bold;">6.94</td> <td style="text-align: left; font-weight: bold;"> </td> <td style="font-weight: bold;"> </td> <td style="text-align: left; font-weight: bold;">$</td> <td style="text-align: right; font-weight: bold;">19,131</td> <td style="text-align: left; font-weight: bold;"> </td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; font-size-adjust: none; font-stretch: normal;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; text-indent: 0.5in; font-size-adjust: none; font-stretch: normal;">The total compensation cost related to unvested stock option awards not yet recognized was $1,184 as of June 30, 2018. The weighted average period over which the total unrecognized compensation cost related to these unvested stock awards will be recognized is 2.22 years. <font style="color: #231f20;">The weighted average fair value of options granted during the six months ended June 30, 2018 and 2017 was $5.97 and $1.52 per share, respectively, or an aggregate grant date fair value of $806 and $269, respectively</font>.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 5.85pt; text-align: justify; text-indent: 19.95pt; font-size-adjust: none; font-stretch: normal;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; text-indent: 0.5in; font-size-adjust: none; font-stretch: normal;">On January 2, 2018 the Compensation Committee of the Company’s Board of Directors granted, and the full Board ratified, an option to acquire an aggregate of 125,000 shares under the 2014 Plan to the Company’s CEO. This option vests 25% on the one-year anniversary of the grant date and monthly thereafter for 36 months, such that the option is vested in full on the four-year anniversary of the grant date. On January 2, 2018 the Company’s Compensation Committee granted, and the full Board ratified, options to each of the then-seated non-employee Directors to acquire 5,000 shares, for an aggregate of 10,000 shares, under the 2014 Plan. These options vest on the one-year anniversary of their grant date. On February 28, 2018 the Compensation Committee of the Company’s Board of Directors accelerated the vesting on stock options issued to consultants such that all unvested shares were vested on that date. This resulted in a one-time expense of $39 during the six months ended June 30, 2018.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; text-indent: 0.5in; font-size-adjust: none; font-stretch: normal;"><b>Determining the Fair Value of Stock Options</b></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; text-indent: 0.5in; font-size-adjust: none; font-stretch: normal;">The Company uses the Black-Scholes pricing model to determine the fair value of stock options. The fair value of each option grant is estimated on the date of the grant. The following assumptions for the periods presented were:</p> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt; font-size-adjust: none; font-stretch: normal;"> </p> <table align="center" style="font: 10pt/normal 'times new roman', times, serif; width: 90%; border-collapse: collapse; font-size-adjust: none; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="font-size: 11pt;" nowrap="nowrap"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="6" nowrap="nowrap">Three months ended<br />June 30,</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="6" nowrap="nowrap">Six months ended June 30,</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-size: 11pt;" nowrap="nowrap"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">2017</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">2017</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 649px; text-align: left;">Expected term (in years)</td> <td style="width: 15px;"> </td> <td style="width: 14px; text-align: left;"> </td> <td style="width: 141px; text-align: right;">-</td> <td style="width: 14px; text-align: left;"> </td> <td style="width: 14px;"> </td> <td style="width: 14px; text-align: left;"> </td> <td style="width: 141px; text-align: right;">5</td> <td style="width: 14px; text-align: left;"> </td> <td style="width: 14px;"> </td> <td style="width: 14px; text-align: left;"> </td> <td style="width: 141px; text-align: right;">5</td> <td style="width: 14px; text-align: left;"> </td> <td style="width: 14px;"> </td> <td style="width: 14px; text-align: left;"> </td> <td style="width: 169px; text-align: right;">5</td> <td style="width: 14px; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: justify;">Risk-free interest rate</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">1.94</td> <td style="text-align: left;">%</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">2.2</td> <td style="text-align: left;">%</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">1.94 – 2.02</font></td> <td style="text-align: left;">%</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left;">Expected volatility</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">104.0</td> <td style="text-align: left;">%</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">0.99</td> <td style="text-align: left;">%</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;" nowrap="nowrap"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">104.0 – 106.2</font></td> <td style="text-align: left;">%</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: justify;">Expected dividend rate</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt; font-size-adjust: none; font-stretch: normal;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; font-size-adjust: none; font-stretch: normal;">The assumptions are based on the following for each of the periods presented:</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;"><i>Valuation Method</i> — The Company estimates the fair value of its stock options using the Black-Scholes option pricing model.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;"><i>Expected Term</i> — The Company estimates the expected term consistent with the simplified method identified by the SEC. The Company elected to use the simplified method because of its limited history of stock option exercise activity and its stock options meet the criteria of the “plain-vanilla” options as defined by the SEC. The simplified method calculates the expected term as the average of the vesting and contractual terms of the award.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;"><i>Volatility</i> — Because the Company has limited trading history by which to determine the volatility of its own common stock price, the expected volatility being used is derived from the historical stock volatilities of a representative industry peer group of comparable publicly listed companies over a period approximately equal to the expected term of the options.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;">  </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;"><i>Risk-free Interest Rate</i> — The risk-free interest rate is based on median U.S. Treasury zero coupon issues with remaining terms similar to the expected term on the options.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;"><i>Expected Dividend </i>— The Company has never declared or paid any cash dividends and does not plan to pay cash dividends in the foreseeable future, and therefore, used an expected dividend yield of zero in the valuation model.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; font-size-adjust: none; font-stretch: normal;"><i>Forfeiture</i> — Beginning in the first quarter of 2017, the Company implemented ASU 2016-09, and elected to true-up calculations at the time of forfeiture, rather than creating an estimate at the time of option issuance.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; font-size-adjust: none; font-stretch: normal;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; text-indent: 0.5in; font-size-adjust: none; font-stretch: normal;">The Company has recorded an expense of <font style="color: #231f20;">$138 and $87 </font>as it relates to stock-based compensation for the three months ended June 30, 2018 and 2017, respectively. The Company has recorded an expense of <font style="color: #231f20;">$331 and $165</font> as it relates to stock-based compensation for the six months ended June 30, 2018 and 2017, respectively:</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; text-indent: 0.5in; font-size-adjust: none; font-stretch: normal;"> </p> <table align="center" style="font: 10pt/normal 'times new roman', times, serif; width: 90%; border-collapse: collapse; font-size-adjust: none; font-stretch: normal;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="6" nowrap="nowrap">Three months ended June 30,</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="6" nowrap="nowrap">Six months ended June 30</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">2017</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">2017</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 677px;">Cost of Revenue</td> <td style="width: 15px;"> </td> <td style="width: 14px; text-align: left;">$</td> <td style="width: 141px; text-align: right;">1</td> <td style="width: 14px; text-align: left;"> </td> <td style="width: 14px;"> </td> <td style="width: 14px; text-align: left;">$</td> <td style="width: 141px; text-align: right;">1</td> <td style="width: 14px; text-align: left;"> </td> <td style="width: 14px;"> </td> <td style="width: 14px; text-align: left;">$</td> <td style="width: 141px; text-align: right;">1</td> <td style="width: 14px; text-align: left;"> </td> <td style="width: 14px;"> </td> <td style="width: 14px; text-align: left;">$</td> <td style="width: 141px; text-align: right;">1</td> <td style="width: 14px; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Engineering and Product Development</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">9</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">12</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">17</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">24</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left;">Sales and Marketing</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">22</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">24</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">51</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">45</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; padding-bottom: 1pt;">General and Administrative</td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">106</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">50</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">262</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">95</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="padding-bottom: 2.5pt;">Total</td> <td style="padding-bottom: 2.5pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">$</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">138</td> <td style="text-align: left; padding-bottom: 2.5pt;"> </td> <td style="padding-bottom: 2.5pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">$</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">87</td> <td style="text-align: left; padding-bottom: 2.5pt;"> </td> <td style="padding-bottom: 2.5pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">$</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">331</td> <td style="text-align: left; padding-bottom: 2.5pt;"> </td> <td style="padding-bottom: 2.5pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">$</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">165</td> <td style="text-align: left; padding-bottom: 2.5pt;"> </td> </tr> </table>

<table style="font: 10pt/normal 'times new roman', times, serif; width: 100%; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0px; margin-bottom: 0px; word-spacing: 0px; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="text-align: justify; vertical-align: top;"> <td style="width: 0.5in; text-align: left;"><b>10.</b></td> <td style="text-align: justify;"><b>Net Income (Loss) Per Share, Basic and Diluted</b></td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Basic earnings (loss) per share (“EPS”) represent net income (loss) attributable to common shareholders divided by the weighted average number of common shares outstanding during the measurement period. Diluted EPS represents net income attributable to common shareholders divided by the weighted average number of common shares outstanding during the measurement period while also giving effect to all potentially dilutive common shares that were outstanding during the period using the treasury stock method.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Basic and diluted net EPS is calculated as follows:</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 100%; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="22" nowrap="nowrap">Three months ended June 30,</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="10" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="10" nowrap="nowrap">2017</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">Shares</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">Net Income</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">EPS</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">Shares</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">Net Loss</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">EPS</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 345px; text-align: left;">Basic EPS</td> <td style="width: 16px;"> </td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 157px; text-align: right;">5,982,711</td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 16px;"> </td> <td style="width: 16px; text-align: left;">$</td> <td style="width: 157px; text-align: right;">1,453</td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 16px;"> </td> <td style="width: 16px; text-align: left;">$</td> <td style="width: 157px; text-align: right;">0.24</td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 16px;"> </td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 157px; text-align: right;">5,340,234</td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 156px; text-align: right;">(850</td> <td style="width: 15px; text-align: left;">)</td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 156px; text-align: right;">(0.16</td> <td style="width: 15px; text-align: left;">)</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Common stock warrants</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">281,224</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; padding-bottom: 1pt;">Common stock options</td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">1,270,911</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">-</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">-</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">-</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: left; padding-bottom: 1pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Diluted EPS</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">7,534,846</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">1,453</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">0.19</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">5,340,234</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">(850</td> <td style="text-align: left;">)</td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">(0.16</td> <td style="text-align: left;">)</td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 100%; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="22" nowrap="nowrap">Six months ended June 30,</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="10" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="10" nowrap="nowrap">2017</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">Shares</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">Net Income</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">EPS</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">Shares</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">Net Loss</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">EPS</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 345px; text-align: left;">Basic EPS</td> <td style="width: 16px;"> </td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 157px; text-align: right;">5,953,818</td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 16px;"> </td> <td style="width: 16px; text-align: left;">$</td> <td style="width: 157px; text-align: right;">2,159</td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 16px;"> </td> <td style="width: 16px; text-align: left;">$</td> <td style="width: 157px; text-align: right;">0.36</td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 16px;"> </td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 157px; text-align: right;">5,286,179</td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 156px; text-align: right;">(1,722</td> <td style="width: 15px; text-align: left;">)</td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 156px; text-align: right;">(0.33</td> <td style="width: 15px; text-align: left;">)</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Common stock warrants</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">256,916</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; padding-bottom: 1pt;">Common stock options</td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">1,195,010</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">-</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">-</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">-</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: left; padding-bottom: 1pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Diluted EPS</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">7,403,498</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">2,159</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">0.29</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">5,286,179</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">(1,722</td> <td style="text-align: left;">)</td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">(0.33</td> <td style="text-align: left;">)</td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The following weighted average shares outstanding of common stock equivalents were excluded from the computation of diluted net loss per share for the three and six months ended June 30, 2018 and 2017 because including them would have been anti-dilutive:</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 85%; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-left: 0.25in; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="6" nowrap="nowrap">Three months ended<br />June 30,</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="6" nowrap="nowrap">Six months ended<br />June 30,</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">2017</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">2017</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td nowrap="nowrap">Weighted average shares outstanding:</td> <td> </td> <td colspan="2" nowrap="nowrap"> </td> <td> </td> <td> </td> <td colspan="2" nowrap="nowrap"> </td> <td> </td> <td> </td> <td colspan="2" nowrap="nowrap"> </td> <td> </td> <td> </td> <td colspan="2" nowrap="nowrap"> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="width: 639px; text-align: left;">Common stock warrants</td> <td style="width: 14px;"> </td> <td style="width: 14px; text-align: left;"> </td> <td style="width: 134px; text-align: right;">-</td> <td style="width: 14px; text-align: left;"> </td> <td style="width: 13px;"> </td> <td style="width: 13px; text-align: left;"> </td> <td style="width: 133px; text-align: right;">839,614</td> <td style="width: 13px; text-align: left;"> </td> <td style="width: 13px;"> </td> <td style="width: 13px; text-align: left;"> </td> <td style="width: 133px; text-align: right;">-</td> <td style="width: 13px; text-align: left;"> </td> <td style="width: 13px;"> </td> <td style="width: 13px; text-align: left;"> </td> <td style="width: 133px; text-align: right;">795,490</td> <td style="width: 13px; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="padding-bottom: 1pt;">Options</td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">135,000</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">2,040,322</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">135,000</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">2,120,936</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="padding-bottom: 2.5pt;">Total</td> <td style="padding-bottom: 2.5pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">135,000</td> <td style="text-align: left; padding-bottom: 2.5pt;"> </td> <td style="padding-bottom: 2.5pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">2,879,936</td> <td style="text-align: left; padding-bottom: 2.5pt;"> </td> <td style="padding-bottom: 2.5pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">135,000</td> <td style="text-align: left; padding-bottom: 2.5pt;"> </td> <td style="padding-bottom: 2.5pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">2,916,426</td> <td style="text-align: left; padding-bottom: 2.5pt;"> </td> </tr> </table>

<table style="widows: 2; text-transform: none; margin-top: 0pt; text-indent: 0px; width: 100%; font: 10pt 'times new roman', times, serif; orphans: 2; margin-bottom: 0pt; letter-spacing: normal; word-spacing: 0px; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="text-align: justify; vertical-align: top;"> <td style="width: 0px;"></td> <td style="width: 0.5in; text-align: left;"><b>11.</b></td> <td style="text-align: justify;"><b>Subsequent Events</b></td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 22.5pt; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">None</p>

<p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 27pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>Recently Issued Accounting Pronouncements</b></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 27pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b> </b></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 27pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><i>Accounting Pronouncements Recently Adopted</i></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 27pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 27pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">In November 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2015-17, Balance Sheet Classification of Deferred Taxes, to reduce complexity and simplify the reporting of deferred income tax liabilities and assets. The amendments in this ASU require that all deferred tax liabilities and assets be classified as noncurrent in a classified balance sheet. The current requirement that deferred tax liabilities and assets of a tax-paying component of an entity be offset and presented as a single amount is not affected by the amendment of this ASU. This standard is effective for the Company’s annual periods beginning after December 15, 2017 and interim periods within annual periods beginning after December 15, 2018, with earlier application permitted. The Company adopted the new standard in the first quarter of 2018. The Company maintains full valuation allowances on all deferred tax balances, and therefore, the adoption of this standard did not have a material impact on its financial statements.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 27pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">In May 2017, the FASB issued ASU No. 2017-09, Compensation — Stock Compensation (Topic 718) — Scope of Modification Accounting. This ASU requires modification accounting for a change in terms or conditions of a share-based payment award only if the fair value, the vesting condition, or the classification of the award (as liability or equity) changes as a result of the changes in terms or conditions. The amendments, which are to be applied prospectively to modifications after adoption, are effective for the Company's annual periods beginning after December 15, 2017, with early adoption permitted. The Company adopted the new standard in the first quarter of 2018 and it did not have a material effect on the Company's financial position or results of operations.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 27pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 27pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><i>Accounting Pronouncements Not Yet Adopted</i></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 27pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 27pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”). The amendment in this ASU provides guidance on the revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The core principle of ASU 2014-09 provides guidance to identify the performance obligations under the contract(s) with a customer and how to allocate the transaction price to the performance obligations in the contract. It further provides guidance to recognize revenue when (or as) the entity satisfies a performance obligation. This standard will replace most existing revenue recognition guidance. On August 8, 2015, the FASB issued ASU 2015-14, which defers the effective date of ASU 2014-09 by one year, and permits early adoption as long as the adoption date is not before the original public entity effective date. This standard is effective for the Company’s annual periods beginning after December 31, 2018 and interim periods within annual periods beginning after December 15, 2018, with early adoption permitted for the year ended December 31, 2017. Since the issuance of ASU 2014-09, the FASB has issued several amendments that clarify certain points, including ASU 2016-08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net), ASU No. 2016-10, Identifying Performance Obligations and Licensing, ASU No. 2016-11, Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16 Pursuant to Staff Announcements at the March 3, 2016 Emerging Issues Task Force Meeting, and ASU No. 2016-12, Narrow-Scope Improvements and Practical Expedients, and ASU No. 2016-20, Technical Corrections and Improvements to Topic 606. The updated revenue standard allows two methods of adoption: (1) retrospectively to each prior period presented (“full retrospective method”), or (2) retrospectively with the cumulative effect recognized in retained earnings as of the date of adoption ("modified retrospective method"). The new standard further requires new disclosures about contracts with customers, including the significant judgments the company has made when applying the guidance. The Company will adopt the new standard effective January 1, 2019, using the modified retrospective transition method. The Company is currently evaluating the impact that this new standard will have on its financial statements.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 27pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">In January 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) ("ASU 2016-02"). Under the new guidance in ASU 2016-02, lessees will be required to recognize the following for all leases (with the exception of short-term leases) at the commencement date: 1) A lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and 2) A right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. Under the new guidance, lessor accounting is largely unchanged, however, certain targeted improvements were made. ASU 2016-02 also simplifies the accounting for sale and leaseback transactions. Lessees (for capital and operating leases) and lessors (for sales-type, direct financing, and operating leases) must apply a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. Lessees and lessors may not apply a full retrospective transition approach. The new standard also requires expanded disclosures regarding leasing arrangements. This standard is effective for the Company’s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company is currently evaluating the impact that this new standard will have on its financial statements.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 27pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). This ASU requires timelier recording of credit losses on loans and other financial instruments held. Instead of reserves based on a current probability analysis, ASU 2016-13 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. All organizations will now use forward-looking information to better inform their credit loss estimates. ASU 2016-13 requires enhanced disclosures regarding significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an organization’s portfolio. These disclosures include qualitative and quantitative requirements that provide information about the amounts recorded in the financial statements. In addition, ASU 2016-13 amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. This standard is effective for the Company’s fiscal years beginning after December 15, 2020. The Company will adopt the new standard in fiscal year 2021. The Company is currently evaluating the effect the new standard will have on its financial statements.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 27pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">In June 2018, the FASB issued ASU No. 2018-07, Compensation — Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (“ASU 2018-07”). This ASU expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. An entity should apply the requirements of Topic 718 to nonemployee awards except for specific guidance on inputs to an option pricing model and the attribution of costs. The ASU specifies that Topic 718 applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards. This standard is effective for the Company’s annual periods beginning after December 15, 2019, including interim periods within those fiscal years. The Company will adopt the new standard in the first quarter of fiscal year 2020. The Company is currently evaluating the impact that this new standard will have on its financial statements.</p>

<table style="font: 10pt/normal 'times new roman', times, serif; width: 80%; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-left: 0.5in; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">June 30, <br />2018</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">December 31,<br />2017</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap"> </td> <td> </td> <td style="text-align: right;" colspan="2" nowrap="nowrap"> </td> <td> </td> <td> </td> <td style="text-align: right;" colspan="2" nowrap="nowrap"> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 928px;">Compensation (1)</td> <td style="width: 13px;"> </td> <td style="width: 13px; text-align: left;">$</td> <td style="width: 126px; text-align: right;">1,964</td> <td style="width: 12px; text-align: left;"> </td> <td style="width: 12px;"> </td> <td style="width: 12px; text-align: left;">$</td> <td style="width: 125px; text-align: right;">2,275</td> <td style="width: 12px; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Board of directors fees (2)</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">15</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">148</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; padding-bottom: 1pt;">Miscellaneous accruals</td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">277</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">247</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; padding-bottom: 2.5pt;">Total accrued expenses</td> <td style="padding-bottom: 2.5pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">$</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">2,256</td> <td style="text-align: left; padding-bottom: 2.5pt;"> </td> <td style="padding-bottom: 2.5pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">$</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">2,670</td> <td style="text-align: left; padding-bottom: 2.5pt;"> </td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>____________ </b></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"></p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 100%; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.5in;"></td> <td style="width: 0.2in;">1.</td> <td style="text-align: justify;">The balance of accrued compensation includes normal accruals for commissions, bonuses, paid time off and other accrued payroll items. In addition, three employees, including the Company’s Chief Executive Officer (“CEO”), agreed to further defer amounts accrued to them as of December 31, 2017. The Company agreed to further delay and continue to accrue these amounts and increase the balance owed by 1% per month beginning January 1, 2017 to no later than January 31, 2019. As of June 30, 2018, the deferred amounts plus additional 1% accruals owed to the CEO were paid in full and the balance was $0.</td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 49.5pt; text-align: justify; color: #000000; text-transform: none; text-indent: -13.5pt; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 100%; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top;"> <td style="width: 0.5in;"></td> <td style="width: 0.2in;">2.</td> <td style="text-align: justify;">Two members of the Company’s board of directors agreed to further defer fees earned from August 2016 to July 2017. The Company agreed to further delay and continue to accrue these amounts and increase the balance owed by 1% per month beginning January 1, 2018 to no later than January 1, 2019. As of June 30, 2018, these deferred amounts plus additional 1% accruals were paid in full and the balance was $0.</td> </tr> </table>

<table style="font: 10pt/normal 'times new roman', times, serif; width: 100%; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="7">June 30, 2018</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="7">December 31, 2017</td> </tr> <tr style="vertical-align: bottom;"> <td style="padding-bottom: 1pt; font-weight: bold;">Lender</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="3">Long-term</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="3">Short-term</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="3">Long-term</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="3">Short-term</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-style: italic;">Loans from Related Parties</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="width: 753px; text-align: left;">Chang Family Trust</td> <td style="width: 16px;"> </td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 157px; text-align: right;"> </td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 16px;"> </td> <td style="width: 16px; text-align: left;">$</td> <td style="width: 157px; text-align: right;">1,216</td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 16px;"> </td> <td style="width: 16px; text-align: left;">$</td> <td style="width: 156px; text-align: right;">1,126</td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 156px; text-align: right;"> </td> <td style="width: 15px; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left;">Chang Family Trust</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">557</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">516</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Glenn J. Krevlin</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">250</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">250</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; font-style: italic;">Other Loans</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left;">Accredited Investor</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">700</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Accredited Investor</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">160</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left;">Accredited Investor</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">80</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Ascentium Capital, LLC</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">22</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left;">Ascentium Capital, LLC</td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">4</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">28</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">16</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">26</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Royal Bank America Leasing, L.P.</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">5</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">28</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; padding-bottom: 1pt;">Ascentium Capital, LLC</td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">2</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">11</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">10</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">11</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: right; padding-bottom: 1pt; font-size: 10pt;">Total</td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">6</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">2,067</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">1,668</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">1,277</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: right; padding-bottom: 1pt; font-size: 10pt;">Debt Discounts</td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">-</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">(6</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">)</td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">-</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">(22</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">)</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: right; padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold;">Total, net of debt discounts</td> <td style="padding-bottom: 2.5pt; font-weight: bold;"> </td> <td style="text-align: left; font-weight: bold; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">$</td> <td style="text-align: right; font-weight: bold; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">6</td> <td style="text-align: left; font-weight: bold; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold;"> </td> <td style="text-align: left; font-weight: bold; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">$</td> <td style="text-align: right; font-weight: bold; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">2,061</td> <td style="text-align: left; font-weight: bold; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold;"> </td> <td style="text-align: left; font-weight: bold; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">$</td> <td style="text-align: right; font-weight: bold; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">1,668</td> <td style="text-align: left; font-weight: bold; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold;"> </td> <td style="text-align: left; font-weight: bold; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">$</td> <td style="text-align: right; font-weight: bold; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">1,255</td> <td style="text-align: left; font-weight: bold; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;"> </td> </tr> </table>

<table align="center" style="font: 10pt/normal 'times new roman', times, serif; width: 90%; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="font-size: 11pt;" nowrap="nowrap"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="6" nowrap="nowrap">Three months ended<br />June 30,</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="6" nowrap="nowrap">Six months ended June 30,</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-size: 11pt;" nowrap="nowrap"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">2017</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">2017</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 649px; text-align: left;">Expected term (in years)</td> <td style="width: 15px;"> </td> <td style="width: 14px; text-align: left;"> </td> <td style="width: 141px; text-align: right;">-</td> <td style="width: 14px; text-align: left;"> </td> <td style="width: 14px;"> </td> <td style="width: 14px; text-align: left;"> </td> <td style="width: 141px; text-align: right;">5</td> <td style="width: 14px; text-align: left;"> </td> <td style="width: 14px;"> </td> <td style="width: 14px; text-align: left;"> </td> <td style="width: 141px; text-align: right;">5</td> <td style="width: 14px; text-align: left;"> </td> <td style="width: 14px;"> </td> <td style="width: 14px; text-align: left;"> </td> <td style="width: 169px; text-align: right;">5</td> <td style="width: 14px; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: justify;">Risk-free interest rate</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">1.94</td> <td style="text-align: left;">%</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">2.2</td> <td style="text-align: left;">%</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">1.94 – 2.02</font></td> <td style="text-align: left;">%</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left;">Expected volatility</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">104.0</td> <td style="text-align: left;">%</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">0.99</td> <td style="text-align: left;">%</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;" nowrap="nowrap"><font style="font-family: 'times new roman', times, serif; font-size: 10pt;">104.0 – 106.2</font></td> <td style="text-align: left;">%</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: justify;">Expected dividend rate</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> </tr> </table>

<table align="center" style="font: 10pt/normal 'times new roman', times, serif; width: 90%; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="6" nowrap="nowrap">Three months ended June 30,</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="6" nowrap="nowrap">Six months ended June 30</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">2017</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">2017</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 677px;">Cost of Revenue</td> <td style="width: 15px;"> </td> <td style="width: 14px; text-align: left;">$</td> <td style="width: 141px; text-align: right;">1</td> <td style="width: 14px; text-align: left;"> </td> <td style="width: 14px;"> </td> <td style="width: 14px; text-align: left;">$</td> <td style="width: 141px; text-align: right;">1</td> <td style="width: 14px; text-align: left;"> </td> <td style="width: 14px;"> </td> <td style="width: 14px; text-align: left;">$</td> <td style="width: 141px; text-align: right;">1</td> <td style="width: 14px; text-align: left;"> </td> <td style="width: 14px;"> </td> <td style="width: 14px; text-align: left;">$</td> <td style="width: 141px; text-align: right;">1</td> <td style="width: 14px; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Engineering and Product Development</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">9</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">12</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">17</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">24</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left;">Sales and Marketing</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">22</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">24</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">51</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">45</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; padding-bottom: 1pt;">General and Administrative</td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">106</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">50</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">262</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">95</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="padding-bottom: 2.5pt;">Total</td> <td style="padding-bottom: 2.5pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">$</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">138</td> <td style="text-align: left; padding-bottom: 2.5pt;"> </td> <td style="padding-bottom: 2.5pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">$</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">87</td> <td style="text-align: left; padding-bottom: 2.5pt;"> </td> <td style="padding-bottom: 2.5pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">$</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">331</td> <td style="text-align: left; padding-bottom: 2.5pt;"> </td> <td style="padding-bottom: 2.5pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">$</td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">165</td> <td style="text-align: left; padding-bottom: 2.5pt;"> </td> </tr> </table>

<table style="font: 10pt/normal 'times new roman', times, serif; width: 100%; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="22" nowrap="nowrap">Three months ended June 30,</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="10" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="10" nowrap="nowrap">2017</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">Shares</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">Net Income</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">EPS</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">Shares</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">Net Loss</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">EPS</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 345px; text-align: left;">Basic EPS</td> <td style="width: 16px;"> </td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 157px; text-align: right;">5,982,711</td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 16px;"> </td> <td style="width: 16px; text-align: left;">$</td> <td style="width: 157px; text-align: right;">1,453</td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 16px;"> </td> <td style="width: 16px; text-align: left;">$</td> <td style="width: 157px; text-align: right;">0.24</td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 16px;"> </td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 157px; text-align: right;">5,340,234</td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 156px; text-align: right;">(850</td> <td style="width: 15px; text-align: left;">)</td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 156px; text-align: right;">(0.16</td> <td style="width: 15px; text-align: left;">)</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Common stock warrants</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">281,224</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; padding-bottom: 1pt;">Common stock options</td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">1,270,911</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">-</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">-</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">-</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: left; padding-bottom: 1pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Diluted EPS</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">7,534,846</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">1,453</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">0.19</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">5,340,234</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">(850</td> <td style="text-align: left;">)</td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">(0.16</td> <td style="text-align: left;">)</td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 100%; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="22" nowrap="nowrap">Six months ended June 30,</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="10" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="10" nowrap="nowrap">2017</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">Shares</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">Net Income</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">EPS</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">Shares</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">Net Loss</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">EPS</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 345px; text-align: left;">Basic EPS</td> <td style="width: 16px;"> </td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 157px; text-align: right;">5,953,818</td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 16px;"> </td> <td style="width: 16px; text-align: left;">$</td> <td style="width: 157px; text-align: right;">2,159</td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 16px;"> </td> <td style="width: 16px; text-align: left;">$</td> <td style="width: 157px; text-align: right;">0.36</td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 16px;"> </td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 157px; text-align: right;">5,286,179</td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 156px; text-align: right;">(1,722</td> <td style="width: 15px; text-align: left;">)</td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;">$</td> <td style="width: 156px; text-align: right;">(0.33</td> <td style="width: 15px; text-align: left;">)</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Common stock warrants</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">256,916</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; padding-bottom: 1pt;">Common stock options</td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">1,195,010</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">-</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">-</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">-</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: left; padding-bottom: 1pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Diluted EPS</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">7,403,498</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">2,159</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">0.29</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">5,286,179</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">(1,722</td> <td style="text-align: left;">)</td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">(0.33</td> <td style="text-align: left;">)</td> </tr> </table>

<table style="font: 10pt/normal 'times new roman', times, serif; width: 85%; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-left: 0.25in; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="6" nowrap="nowrap">Three months ended<br />June 30,</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="6" nowrap="nowrap">Six months ended<br />June 30,</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="text-align: center;" nowrap="nowrap"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">2017</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2" nowrap="nowrap">2017</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td nowrap="nowrap">Weighted average shares outstanding:</td> <td> </td> <td colspan="2" nowrap="nowrap"> </td> <td> </td> <td> </td> <td colspan="2" nowrap="nowrap"> </td> <td> </td> <td> </td> <td colspan="2" nowrap="nowrap"> </td> <td> </td> <td> </td> <td colspan="2" nowrap="nowrap"> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="width: 639px; text-align: left;">Common stock warrants</td> <td style="width: 14px;"> </td> <td style="width: 14px; text-align: left;"> </td> <td style="width: 134px; text-align: right;">-</td> <td style="width: 14px; text-align: left;"> </td> <td style="width: 13px;"> </td> <td style="width: 13px; text-align: left;"> </td> <td style="width: 133px; text-align: right;">839,614</td> <td style="width: 13px; text-align: left;"> </td> <td style="width: 13px;"> </td> <td style="width: 13px; text-align: left;"> </td> <td style="width: 133px; text-align: right;">-</td> <td style="width: 13px; text-align: left;"> </td> <td style="width: 13px;"> </td> <td style="width: 13px; text-align: left;"> </td> <td style="width: 133px; text-align: right;">795,490</td> <td style="width: 13px; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="padding-bottom: 1pt;">Options</td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">135,000</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">2,040,322</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">135,000</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">2,120,936</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="padding-bottom: 2.5pt;">Total</td> <td style="padding-bottom: 2.5pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">135,000</td> <td style="text-align: left; padding-bottom: 2.5pt;"> </td> <td style="padding-bottom: 2.5pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">2,879,936</td> <td style="text-align: left; padding-bottom: 2.5pt;"> </td> <td style="padding-bottom: 2.5pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">135,000</td> <td style="text-align: left; padding-bottom: 2.5pt;"> </td> <td style="padding-bottom: 2.5pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">2,916,426</td> <td style="text-align: left; padding-bottom: 2.5pt;"> </td> </tr> </table>

1003000

1847000

1812000

700000

837000

85000

171000

101000

198000

38000 93000 28000 61000

322000

427000

129000

180000

47000

95000

26000

51000

2275000

1964000

148000 15000

247000

277000

0.01 1 1 2 2 2 2

0.561

0.567

0.566

0.239

0.503

0.225

0.539

0.177

0.451

0.377

1668000

1126000

516000

16000

10000

6000

4000

2000

1668000

6000

1277000 700000 160000 80000 22000 26000 11000 28000 250000 2067000 1216000 557000 0 0 0 0 28000 11000 5000 250000 22000 6000 1255000 2061000

P36M

P30M

17000

17500

18000

15500

16000

16500

17000 34000 18000 35000

P24M

P36M

P24M

P12M

P2Y

0.10

0.05

0.10

0.089

0.073

0.091

0.10

0.103

1000000

500000

700000

160000

80000

2400

1000

250000

5600

50000 50000

1.75

1.85

2.60

115000

231000

82000

187000

1000000

500000

700000

160000

80000

74000

140000

33000

250000

63000

179000

-179000

1855138

1878350

135000

105378

6410

1508900

2.69

3.09

8.00

2.32

3.44

2.77

P7Y5M23D

P7Y2M23D

P6Y11M9D

9850000

23216000

19131000

P5Y

0.0194

0.0202

0.00

0.022

1.040

1.062

0.00

0.0099

0.00

87000

1000

12000

24000

50000

165000

1000

24000

45000

95000

138000

1000

9000

22000

106000

331000

1000

17000

51000

262000

5000

125000

987337

10000

450000

2783616

407500

P10Y

188640

1500000

204943

235090

0.04 0.04 0.04 0.04 0.04

1184000

P2Y2M19D

1.52

5.97

269000 806000

39000

281224

256916

1270911

1195010

-850000

-1722000

1453000

2159000

0 0 0 0

-850000

-1722000

1453000

2159000

2879936

839614

2040322

2916426

795490

2120936

135000

P2Y P2Y P2Y P2Y P2Y P2Y P3Y

288000

-70000

1508000

-603000

-243000

37000

47000

547000

-713000

56000

3500

4400

5300

500000

7000

191000

0.10

162000

63000

<table style="font: 10pt/normal 'times new roman', times, serif; width: 100%; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="text-align: justify; vertical-align: top;"> <td style="width: 0px;"></td> <td style="width: 0.5in; text-align: left;"><font style="color: #231f20;"><b>8.</b></font></td> <td style="text-align: justify;"><font style="color: #231f20;"><b>Loans Payable</b></font></td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 100%; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="7">June 30, 2018</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="7">December 31, 2017</td> </tr> <tr style="vertical-align: bottom;"> <td style="padding-bottom: 1pt; font-weight: bold;">Lender</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="3">Long-term</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="3">Short-term</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="3">Long-term</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="3">Short-term</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; font-style: italic;">Loans from Related Parties</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="width: 753px; text-align: left;">Chang Family Trust</td> <td style="width: 16px;"> </td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 157px; text-align: right;"> </td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 16px;"> </td> <td style="width: 16px; text-align: left;">$</td> <td style="width: 157px; text-align: right;">1,216</td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 16px;"> </td> <td style="width: 16px; text-align: left;">$</td> <td style="width: 156px; text-align: right;">1,126</td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 156px; text-align: right;"> </td> <td style="width: 15px; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left;">Chang Family Trust</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">557</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">516</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Glenn J. Krevlin</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">250</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">250</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left; font-style: italic;">Other Loans</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left;">Accredited Investor</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">700</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Accredited Investor</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">160</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left;">Accredited Investor</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">80</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Ascentium Capital, LLC</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">22</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left;">Ascentium Capital, LLC</td> <td> </td> <td style="text-align: left;">$</td> <td style="text-align: right;">4</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">28</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">16</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">26</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: left;">Royal Bank America Leasing, L.P.</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">5</td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">28</td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left; padding-bottom: 1pt;">Ascentium Capital, LLC</td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">2</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">11</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">10</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">11</td> <td style="text-align: left; padding-bottom: 1pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;"> </td> <td style="text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: right; padding-bottom: 1pt; font-size: 10pt;">Total</td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">6</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">2,067</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">1,668</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">1,277</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: right; padding-bottom: 1pt; font-size: 10pt;">Debt Discounts</td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">-</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">(6</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">)</td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">-</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="padding-bottom: 1pt;"> </td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;"> </td> <td style="text-align: right; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">(22</td> <td style="text-align: left; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;">)</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: right; padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold;">Total, net of debt discounts</td> <td style="padding-bottom: 2.5pt; font-weight: bold;"> </td> <td style="text-align: left; font-weight: bold; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">$</td> <td style="text-align: right; font-weight: bold; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">6</td> <td style="text-align: left; font-weight: bold; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold;"> </td> <td style="text-align: left; font-weight: bold; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">$</td> <td style="text-align: right; font-weight: bold; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">2,061</td> <td style="text-align: left; font-weight: bold; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold;"> </td> <td style="text-align: left; font-weight: bold; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">$</td> <td style="text-align: right; font-weight: bold; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">1,668</td> <td style="text-align: left; font-weight: bold; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold;"> </td> <td style="text-align: left; font-weight: bold; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">$</td> <td style="text-align: right; font-weight: bold; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;">1,255</td> <td style="text-align: left; font-weight: bold; border-bottom-color: black; border-bottom-width: 2.5pt; border-bottom-style: double;"> </td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 27pt; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b> </b> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><i>Loans from Related Parties</i></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">On January 15, 2016, the Company entered into a loan agreement with the Chang Family Trust, one of its significant stockholders. Pursuant to the loan agreement, the Company obtained a $1,000 unsecured loan, which initially had a 24-month term, at a fixed interest rate of 10% per annum. Under the loan agreement, the Company will pay $1,000 of principal plus all accrued and unpaid interest at maturity. The Company may prepay the notes at any time prior to maturity without penalty. The notes must be repaid prior to maturity in the event of default, and the Company agreed not to incur additional indebtedness in excess of $50 without the lender’s prior consent, which is not to be unreasonably withheld. In connection therewith, the Company issued the Chang Family Trust a two-year warrant to purchase 114,286 shares of its common stock at an exercise price of $1.75 per share. The relative fair value of this warrant was recorded as a debt discount on the Company’s balance sheet and partially offsets the total balance due for loans payable. The warrants were exercised in full in December 2017 and are no longer outstanding. As of the date of this filing, the Company is in compliance with all terms of this loan.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">On January 21, 2016, the Company entered into a second loan agreement with the Chang Family Trust. Pursuant to this loan agreement, the Company obtained a $500 unsecured loan, which initially had a 24-month term at a fixed interest rate of 5% per annum. Under this loan agreement, the Company will pay $500 of principal plus all accrued and unpaid interest at maturity. The Company may prepay the notes at any time prior to maturity without penalty. The notes must be repaid prior to maturity in the event of default, and the Company agreed not to incur additional indebtedness in excess of $50 without the lender’s prior consent, which is not to be unreasonably withheld. In connection therewith, the Company issued the Chang Family Trust a two-year warrant to purchase 114,286 shares of its common stock at an exercise price of $1.75 per share. The relative fair value of this warrant was recorded as a debt discount on the Company’s balance sheet and partially offsets the total balance due for loans payable. The warrants were exercised in full in December 2017 and are no longer outstanding. As of the date of this filing, the Company is in compliance with all terms of this loan.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">On May 2, 2017, the Company entered into an amendment regarding the outstanding promissory notes and warrants issued in January 2016 to the Chang Family Trust. As amended, the maturity date for each note has now been extended by 12 months to January 2019, and the interest rate on the $500 note has been increased to 10.0% per annum for the final 12 months of its term. In each case, interest will accrue on the unpaid principal and accrued interest as of the original two-year maturity date in the final year term of the notes. The other terms of the notes remain unchanged. Additionally, as issued, the warrants were not exercisable, absent receipt of stockholder approval, if after such exercise the holder would be the beneficial owner of more than 19.99% of the Company’s common stock. This condition was removed by the amendments, and accordingly, stockholder approval is no longer required. In connection with the foregoing amendment, the Company issued the Chang Family Trust a warrant to purchase 134,616 shares of its common stock at an exercise price of $2.60 per share. In accordance with FASB ASC 815, these warrants were classified within permanent equity. The warrant expires January 21, 2022, three years after the latest maturity date of the promissory notes, as amended. As part of the amendment, the fair value of the warrants were considered in the calculation when determining whether this amendment resulted in a modification or extinguishment of the original loans in accordance with FASB ASC 470, the Company recorded the amendment as an extinguishment of the original loans which resulted in a loss on extinguishment of $179 as recorded in the statements of operations.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">On November 21, 2016, the Company entered into a loan agreement with Glenn J. Krevlin, one of its significant stockholders. Pursuant to the loan agreement, the Company obtained a $250 unsecured loan for a 24-month term at a fixed interest rate of 10% per annum. Under the loan agreement, the Company will pay $250 of principal plus all accrued but unpaid interest at maturity. The notes may be prepaid at any time prior to maturity without penalty. The notes must be repaid prior to maturity in the event of default. In connection therewith, the Company issued the accredited investor a two-year warrant to purchase 28,378 shares of common stock at an exercise price of $1.85 per share. The warrants were not able to be exercised absent receipt of stockholder approval if after such exercise the holder would be the beneficial owner of more than 9.99% of the Company’s common stock. The relative fair value of this warrant was recorded as a debt discount on the Company’s balance sheet and partially offsets the total balance due for loans payable. As of the date of this filing, the Company is in compliance with all terms of this loan, and the warrants were exercised in full in January 2018.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><i>Other Loans</i></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">On March 31, 2016, the Company entered into a loan agreement with an accredited investor. Pursuant to the loan agreement, the Company obtained a $700 unsecured loan for a 24-month term at a fixed interest rate of 10% per annum. Under the loan agreement, the Company will pay $700 of principal plus all accrued but unpaid interest at maturity. The notes may be prepaid at any time prior to maturity without penalty. The notes must be repaid prior to maturity in the event of default. In connection therewith, the Company issued the accredited investor a two-year warrant to purchase 79,459 shares of common stock at an exercise price of $1.85 per share. The warrants were not able to be exercised absent receipt of stockholder approval if after such exercise the holder would be the beneficial owner of more than 4.99% of the Company’s common stock. The relative fair value of this warrant was recorded as a debt discount on the Company’s balance sheet and partially offsets the total balance due for loans payable. The warrants were exercised in full in November 2017. During the quarter ended March 31, 2018, the Company has paid this loan and all associated interest in full.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">On April 5, 2016, the Company entered into a loan agreement with an accredited investor. Pursuant to the loan agreement, the Company obtained a $160 unsecured loan for a 24-month term at a fixed interest rate of 10% per annum. Under the loan agreement, the Company will pay $160 of principal plus all accrued but unpaid interest at maturity. The notes may be prepaid at any time prior to maturity without penalty. The notes must be repaid prior to maturity in the event of default. In connection therewith, the Company issued the accredited investor a two-year warrant to purchase 18,162 shares of common stock at an exercise price of $1.85 per share. The warrants may not be exercised absent receipt of stockholder approval if after such exercise the holder would be the beneficial owner of more than 4.99% of the Company’s common stock. The relative fair value of this warrant was recorded as a debt discount on the Company’s balance sheet and partially offsets the total balance due for loans payable. The warrants were fully exercised as of December 31, 2017. As of the date of this filing, the Company has paid this loan and all associated interest in full.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">On May 20, 2016, the Company entered into a loan agreement with an accredited investor. Pursuant to the loan agreement, the Company obtained a $80 unsecured loan for a 24-month term at a fixed interest rate of 10% per annum. Under the loan agreement, the Company will pay $80 of principal plus all accrued but unpaid interest at maturity. The notes may be prepaid at any time prior to maturity without penalty. The notes must be repaid prior to maturity in the event of default. In connection therewith, the Company issued the accredited investor a two-year warrant to purchase 9,081 shares of common stock at an exercise price of $1.85 per share. The warrants may not be exercised absent receipt of stockholder approval if after such exercise the holder would be the beneficial owner of more than 4.99% of the Company’s common stock. The relative fair value of this warrant was recorded as a debt discount on the Company’s balance sheet and partially offsets the total balance due for loans payable. The warrants were partially exercised in December 2017 for an aggregate of 7,323 shares of our common stock with the remainder being exercised in March 2018. As of the date of this filing, the Company has paid this loan and all associated interest in full.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The Company uses the Black-Scholes pricing model to determine the fair value of warrants. The fair value of each warrant is estimated on the date of grant. There were no warrants issued during the three or six months ended June 30, 2018. The fair value of warrants issued in conjunction with the related party loans during the three and six months ended June 30, 2017 was $288. The fair value of the warrants granted is estimated on the date of grant using the Black-Scholes pricing model and the following assumptions for the periods presented:</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 100%; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom;"> <td nowrap="nowrap"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td nowrap="nowrap" style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="6">Three months ended<br />June 30,</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td nowrap="nowrap" style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="6">Six months ended June 30,</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom;"> <td nowrap="nowrap"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td nowrap="nowrap" style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td nowrap="nowrap" style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2">2017</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td nowrap="nowrap" style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2">2018</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> <td nowrap="nowrap" style="text-align: center; font-weight: bold; border-bottom-color: black; border-bottom-width: 1pt; border-bottom-style: solid;" colspan="2">2017</td> <td style="padding-bottom: 1pt; font-weight: bold;"> </td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="width: 753px; text-align: left;">Expected term (in years)</td> <td style="width: 16px;"> </td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 157px; text-align: right;">-</td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 16px;"> </td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 157px; text-align: right;">4.75</td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 16px;"> </td> <td style="width: 16px; text-align: left;"> </td> <td style="width: 156px; text-align: right;">-</td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 15px;"> </td> <td style="width: 15px; text-align: left;"> </td> <td style="width: 156px; text-align: right;">4.75</td> <td style="width: 15px; text-align: left;"> </td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: justify;">Risk-free interest rate</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">1.27</td> <td style="text-align: left;">%</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">1.27</td> <td style="text-align: left;">%</td> </tr> <tr style="vertical-align: bottom; background-color: #cceeff;"> <td style="text-align: left;">Expected volatility</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">104.6</td> <td style="text-align: left;">%</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">104.6</td> <td style="text-align: left;">%</td> </tr> <tr style="vertical-align: bottom; background-color: white;"> <td style="text-align: justify;">Expected dividend rate</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> <td> </td> <td style="text-align: left;"> </td> <td style="text-align: right;">-</td> <td style="text-align: left;">%</td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">On July 8, 2016, the Company entered into an additional software license financing agreement with Ascentium Capital, LLC. Pursuant to the agreement, the Company obtained a $74 loan for a 36-month term at a fixed interest rate of 8.9% per annum. Under the loan agreement, the Company agreed to make monthly payments of $2.4 of principal and accrued interest. The loan may be prepaid at any time prior to maturity without penalty. The agreement provides for customary events of default. As of the date of this filing, the Company is in compliance with all terms of this loan.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px 0pt 27pt; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">On July 11, 2016, the Company entered into a secured equipment financing agreement with Royal Bank America Leasing, L.P. Pursuant to the agreement, the Company obtained a $140 loan for a 36-month term at a fixed interest rate of 7.3% per annum, which is secured by related equipment. The loan is to be disbursed in three installments. The first installment was for $37. The second installment for $47 will be disbursed in July 2017, and the third installment for $56 will be disbursed in July 2018. Under the loan agreement, the Company will pay $3.5 of principal and accrued interest for each of the first 12 months (July 2016 through July 2017), $4.4 of principal and accrued interest for each of months 13-24 (July 2017 through July 2018), and $5.3 of principal and accrued interest for each of months 25-36 (July 2018 through July 2019). The loan may be prepaid at any time only in accordance with the agreement. The agreement provides for customary events of default. The Company elected not to receive the third installment of this loan and as a result, as of July 2018, this loan and all associated interest have been paid in full.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">On October 2, 2016, the Company entered into a secured equipment financing agreement with Ascentium Capital, LLC. Pursuant to the agreement, the Company obtained a $33 loan for a 36-month term at a fixed interest rate of 9.1% per annum. Under the loan agreement, the Company agreed to make monthly payments of $1.0 of principal and accrued interest. The loan may be prepaid at any time prior to maturity without penalty. The agreement provides for customary events of default. As of the date of this filing, the Company is in compliance with all terms of this loan.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">On April 1, 2017, the Company entered into a software license financing agreement with Ascentium Capital, LLC. Pursuant to the agreement, the Company obtained a $63 loan for a 12-month term at a fixed interest rate of 10.3% per annum to finance its upfront software licensing fee. The Company agreed to pay $5.6 of principal and accrued interest for each month of the term. The loan may be prepaid at any time prior to maturity without penalty. The agreement provides for customary events of default. In April 2018, the Company repaid this loan and it is no longer outstanding.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">For the three months ended June 30, 2018 and 2017, interest expense was $82 and $115, respectively, which included amortization of the debt discount of $4 and $28, respectively. For the six months ended June 30, 2018 and 2017, interest expense was $187 and $231, respectively, which included amortization of debt discount of $16 and $80, respectively.</p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; color: #231f20; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b><i>Indemnification Obligations</i></b></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #231f20; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0pt 0px; text-align: justify; color: #231f20; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The Company enters into agreements with customers, partners, lenders, consultants, lessors, contractors, sales representatives and parties to certain transactions in the ordinary course of the Company’s business. These agreements may require the Company to indemnify the other party against third party claims alleging that its product infringes a patent or copyright. Certain of these agreements require the Company to indemnify the other party against losses arising from: a breach of representations or covenants, claims relating to property damage, personal injury or acts or omissions of the Company, its employees, agents or representatives. The Company has also agreed to indemnify the directors and certain of the officers and employees in accordance with the by-laws of the Company. These indemnification provisions will vary based upon the nature and terms of the agreements. In many cases, these indemnification provisions do not contain limits on the Company’s liability, and the occurrence of contingent events that will trigger payment under these indemnities is difficult to predict. As a result, the Company cannot estimate its potential liability under these indemnities. The Company believes that the likelihood of conditions arising that would trigger these indemnities is remote and, historically, the Company had not made any significant payment under such indemnification provisions. Accordingly, the Company has not recorded any liabilities relating to these agreements. In certain cases, the Company has recourse against third parties with respect to the aforesaid indemnities, and the Company believes it maintains adequate levels of insurance coverage to protect the Company with respect to potential claims arising from such agreements.</p>

P4Y9M P4Y9M 0.0127 1.046 0.00 0.0127 1.046 0.00 0.00 0.00 0.00 0.00 0.00 0.00 179000 179000 114286 114286 79459 18162 9081 28378 134616 The balance of accrued compensation includes normal accruals for commissions, bonuses, paid time off and other accrued payroll items. In addition, three employees, including the Company's Chief Executive Officer ("CEO"), agreed to further defer amounts accrued to them as of December 31, 2017. The Company agreed to further delay and continue to accrue these amounts and increase the balance owed by 1% per month beginning January 1, 2017 to no later than January 31, 2019. As of June 30, 2018, the deferred amounts plus additional 1% accruals owed to the CEO were paid in full and the balance was $0. Two members of the Company's board of directors agreed to further defer fees earned from August 2016 to July 2017. The Company agreed to further delay and continue to accrue these amounts and increase the balance owed by 1% per month beginning January 1, 2018 to no later than January 1, 2019. As of June 30, 2018, these deferred amounts plus additional 1% accruals were paid in full and the balance was $0. 0001554859us-gaap:BoardOfDirectorsChairmanMemberus-gaap:EmployeeStockOptionMembersmlr:StockIncentivePlan2014Member2018-01-012018-01-02 0.25 P4Y 0001554859smlr:NonEmployeeDirectorsMemberus-gaap:EmployeeStockOptionMembersmlr:StockIncentivePlan2014Member2018-01-012018-01-02 P1Y

7323

EX-101.SCH 6 smlr-20180630.xsd XBRL TAXONOMY EXTENSION SCHEMA 001 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Balance Sheets link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Condensed Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Condensed Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Disclosure - Basis of Presentation link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Going Concern link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Assets for Lease, net link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Property and Equipment, net link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Accrued Expenses link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Concentration of Credit Risk link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Facilities Leases link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Loans Payable link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Stock Option Plan link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Net Income (Loss) Per Share, Basic and Diluted link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Summary of Significant Accounting Policies and Estimates (Policies) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Assets for Lease, net (Tables) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Property and Equipment, net (Tables) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Accrued Expenses (Tables) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Loans Payable (Tables) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Stock Option Plan (Tables) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Net Income (Loss) Per Share, Basic and Diluted (Tables) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Going Concern (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Assets for Lease, net - Summary of assets for lease (Details) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Assets for Lease, net (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Property and Equipment, net (Details) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Property and Equipment, net (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Accrued Expenses - Summary of accrued expenses (Details) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Accrued Expenses (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Concentration of Credit Risk (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Facilities Leases (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Loans Payable (Details) link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Loans Payable (Details 1) link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Loans Payable (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Loans Payable (Detail Textuals 1) link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - Stock Option Plan - Summary of stock-based compensation activity (Details) link:presentationLink link:definitionLink link:calculationLink 038 - Disclosure - Stock Option Plan - Weighted-average Black-Scholes fair value assumptions (Details 1) link:presentationLink link:definitionLink link:calculationLink 039 - Disclosure - Stock Option Plan - Stock-based compensation (Details 2) link:presentationLink link:definitionLink link:calculationLink 040 - Disclosure - Stock Option Plan (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 041 - Disclosure - Net Income (Loss) Per Share, Basic and Diluted (Details) link:presentationLink link:definitionLink link:calculationLink 042 - Disclosure - Net Income (Loss) Per Share, Basic and Diluted (Details 1) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 smlr-20180630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 smlr-20180630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 smlr-20180630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information [Abstract] Entity Registrant Name Entity Central Index Key Trading Symbol Current Fiscal Year End Date Entity Filer Category Entity Common Stock, Shares Outstanding Document Type Document Period End Date Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Income Statement [Abstract] Revenues Revenues Operating Expenses [Abstract] Operating expenses: Cost of Revenue Cost of revenues Cost of Goods and Services Sold Engineering and product development Selling and Marketing Expense Sales and marketing General and Administrative Expense General and administrative Operating Expenses Total operating expenses Operating Income (Loss) Income (loss) from operations Interest Expense Interest expense Interest expense Interest Expense, Related Party Interest expense - related parties Related party interest expense Loss On Extinguishment Of Debt Loss on extinguishment of loans Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Loss on extinguishment of loans Other Nonoperating Expense Other expense Other expense Nonoperating Income (Expense) Other expense Net Income (Loss) Attributable to Parent Net loss Net income (loss) Net income (loss) Net loss Earnings Per Share, Basic and Diluted [Abstract] Net income (loss) per share: Earnings Per Share, Basic Basic (in dollars per share) Basic EPS (in dollars per share) Earnings Per Share, Diluted Diluted (in dollars per share) Diluted EPS (in dollars per share) Weighted Average Number of Shares Outstanding, Diluted [Abstract] Weighted average number of shares used in computing: basic and diluted loss per share Weighted average shares outstanding: Weighted Average Number of Shares Outstanding, Basic Basic (in shares) Basic EPS (in shares) Weighted Average Number of Shares Outstanding, Diluted Diluted (in shares) Diluted EPS (in shares) Statement of Financial Position [Abstract] Assets [Abstract] Assets Assets, Current [Abstract] Current Assets: Cash and Cash Equivalents, at Carrying Value Cash CASH, BEGINNING OF PERIOD CASH, END OF PERIOD Accounts Receivable, Net, Current Trade accounts receivable, net of allowance for doubtful accounts of $35 and $35, respectively Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Assets, Current Total current assets Capital Leases, Balance Sheet, Assets by Major Class, Net Assets for lease, net Assets for lease, net Property, Plant and Equipment, Net Capital assets, net Property and equipment, net Capital assets, net Deposits Assets, Noncurrent Long-term deposits Assets Total assets Liabilities and Equity [Abstract] Liabilities and Stockholders' Equity (Deficit) Liabilities, Current [Abstract] Current liabilities: Accounts Payable, Current Accounts payable Accrued Liabilities, Current Accrued expenses Total Accrued Expenses Total accrued expenses Deferred Revenue, Current Deferred revenue Interest Payable, Current Accrued interest Accounts Payable and Accrued Liabilities, Current Accrued interest - related party Loans Payable, Current, Total Loans payable net of debt discount of $0 and $9, respectively Due to Related Parties, Current Related party loans payable net of debt discount of $6 and $13, respectively Liabilities, Current Total current liabilities Liabilities, Noncurrent [Abstract] Long-term liabilities: Deferred rent Deferred rent Loans Payable, Noncurrent, Total Loans payable, less current portion Due to Related Parties, Noncurrent Related party loans payable, less current portion Related Party, Total, net of debt discounts Liabilities, Noncurrent Total long-term liabilities Total long-term liabilities Stockholders' Equity Attributable to Parent [Abstract] Stockholders' equity (deficit): Common Stock, Value, Issued Common stock, $0.001 par value; 50,000,000 shares authorized; 6,048,397 and 5,902,244 shares issued, and 6,023,397 and 5,877,244 outstanding (treasury shares of 25,000 and 25,000), respectively Additional Paid in Capital Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Stockholders' Equity Attributable to Parent Stockholders' equity Total stockholders' equity (deficit) Balance Balance Liabilities and Equity Total liabilities and stockholders' equity (deficit) Allowance for Doubtful Accounts Receivable, Current Allowance for doubtful accounts on trade accounts receivable (in dollars) Debt Instrument, Unamortized Discount, Current Debt discount on loans payable, current (in dollars) Related Party Debt Discount Current Debt discount on related party loans payable, current (in dollars) Represents current portion of related party debt discount. Common Stock, Par or Stated Value Per Share Common stock, par value (in dollars per share) Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Number of common stock issued in connection with notes Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding Treasury Stock, Shares Treasury stock, shares Statement of Cash Flows [Abstract] Net Cash Provided by (Used in) Operating Activities [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Reconciliation of Net Income (Loss) to Net Cash Provided by Operating Activities: Amortization of Debt Discount (Premium) Amortization of debt discount Amortization of debt discount Accretion Expense Total accretion Accretion of non-cash interest Gain (Loss) on Extinguishment of Debt Loss on extinguishment of loans Loss on extinguishment of debt Loss on extinguishment of debt Depreciation, Depletion and Amortization, Nonproduction Depreciation Gain (Loss) on Sale of Leased Assets, Net, Operating Leases Loss on disposal of assets for lease Loss on disposal of assets for lease Provision for Doubtful Accounts Reserve against its accounts receivable Allowance for doubtful accounts Share-based Compensation Stock-based compensation expense Stock-based compensation expense Increase (Decrease) in Operating Capital [Abstract] Changes in Operating Assets and Liabilities: Increase (Decrease) in Accounts Receivable Trade accounts receivable Trade accounts receivable Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Prepaid expenses and other current assets Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Accrued Liabilities Accrued expenses Increase (Decrease) in Deferred Revenue Deferred revenue Net Cash Provided by (Used in) Operating Activities Net Cash Provided By (Used in) Operating Activities Net Cash Provided by (Used in) Investing Activities [Abstract] CASH FLOWS FROM INVESTING ACTIVITIES: Payments to Acquire Property, Plant, and Equipment Additions to property and equipment Additions to property and equipment Payments to Acquire Equipment on Lease Purchase of assets for lease Net Cash Provided by (Used in) Investing Activities Net Cash Used in Investing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from Issuance of Common Stock Proceeds from issuance of common stock Exercise of warrants Proceeds from Stock Options Exercised Exercise of stock options Proceeds from (Repayments of) Debt Proceeds from loans payable Repayments of Long-term Debt Payments of loans payable Payments of loans payable Net Cash Provided by (Used in) Financing Activities Net Cash (Used in) Provided by Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) INCREASE (DECREASE) IN CASH Interest Paid, Excluding Capitalized Interest, Operating Activities Cash paid for interest Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Supplemental disclosure of noncash financing activity: Reclassification of accrued interest to debt upon extinguishment The reclassification of accrued interest to debt upon extinguishment in noncash financing activities. Fair Value Adjustment of Warrants Fair value of warrants with promissory notes Fair value of warrants issued to lenders Accounting Policies [Abstract] Basis of Accounting [Text Block] Basis of Presentation Basis of Accounting [Text Block] Going Concern [Abstract] Substantial Doubt about Going Concern [Text Block] Going Concern Leases, Capital [Abstract] Capital Leases in Financial Statements of Lessee Disclosure [Text Block] Assets for Lease, net Property, Plant and Equipment [Abstract] Property, Plant and Equipment Disclosure [Text Block] Property and Equipment, net Accrued Liabilities, Current [Abstract] Accrued Liabilities Disclosure [Text Block] Accrued Expenses The entire disclosure for accrued liabilities at the end of the reporting period. Risks and Uncertainties [Abstract] Concentration Risk Disclosure [Text Block] Concentration of Credit Risk Leases [Abstract] Lessee, Operating Leases [Text Block] Facilities Leases Loans Payable [Abstract] Loans Payable [Text Block] Loans Payable The entire disclosure for loans payable at the end of the reporting period. Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Stock Option Plan Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Stock Option Plan Earnings Per Share [Abstract] Net income (loss) per share: Earnings Per Share [Text Block] Net Income (Loss) Per Share, Basic and Diluted Subsequent Events [Abstract] Subsequent Events [Text Block] Subsequent Events Basis of Accounting, Policy [Policy Text Block] Basis of Presentation New Accounting Pronouncements, Policy [Policy Text Block] Recently Issued Accounting Pronouncements Schedule of Capital Leased Assets [Table Text Block] Schedule of assets for lease Property, Plant and Equipment [Table Text Block] Schedule of property and equipment, net Schedule of Accrued Liabilities [Table Text Block] Schedule of accrued expenses Schedule of Debt [Table Text Block] Schedule of loans payable Schedule of Loans Payable Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Schedule for fair value of the warrants Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Schedule of stock option activity Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of weighted-average Black-Scholes fair value assumptions Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block] Schedule of stock-based compensation Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of basic and diluted net EPS Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of weighted average shares outstanding excluded from the computation of diluted net loss per share Working Capital Deficit Working capital deficit Working capital of a business which is used in its day-to-day trading operations, calculated as the current assets minus the current liabilities. Capital Leased Assets, Gross Assets for lease Capital Leases, Lessee Balance Sheet, Assets by Major Class, Accumulated Depreciation Less: Accumulated Depreciation Less: accumulated depreciation Depreciation, Nonproduction Depreciation expense Depreciation Accumulated Depreciation Reduction For Returned Items Reduction to accumulated depreciation for returned items This element represents reduction in accumulated depreciation for returned items. Property, Plant and Equipment, Gross Capital assets Capital assets Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Less: accumulated depreciation Less: accumulated depreciation Depreciation Depreciation expense Depreciation Employee-related Liabilities, Current Compensation Board Of Directors Fees Board of directors fees Represents board of directors fees. Other Accrued Liabilities, Current Miscellaneous accruals Percentage Increase In Balance Owe Percentage increase in balance owed per month Represents percentage increase in balance owe. Accounts Payable and Other Accrued Liabilities, Current Deferred amounts plus additional 1% accruals Concentration Risk [Table] Concentration Risk Type [Axis] Concentration Risk Type [Domain] Customer Concentration Risk [Member] Customer concentration risk Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Sales Revenue, Net [Member] Revenue Accounts Receivable [Member] Accounts receivable Customer [Axis] Customer [Domain] Customer One Concentration Risk [Member] Customer one Customer One. Customer Two Concentration Risk [Member] Customer two Customer Two. Customer Three Concentration Risk [Member] Customer three Customer three. Concentration Risk [Line Items] Concentration Risk Number Of Customers Number of customers Represents number of major customers in concentration risk. Concentration Risk, Percentage Concentration risk percentage Property Subject to or Available for Operating Lease, by Major Property Class [Table] Lease Arrangement, Type [Axis] Lease Arrangement, Type [Domain] Lease Agreement [Member] Lease Agreement Represents information of operating lease. Sub Lease Agreement [Member] Sub Lease Agreement Represents information of sub lease agreement. Lease Agreement Period [Axis] Represents information of lease agreement. Lease Agreement Period [Domain] Represents information of lease agreement. Lease Term From February 2015 To January 2016 [Member] Lease term from February 2015 to January 2016 Represents information of term specified for lease agreement. Lease Term From February 2016 To January 2017 [Member] Lease term from February 2016 to January 2017 Represents information of term specified for lease agreement. Lease Term From February 2017 To January 2018 [Member] Lease term from February 2017 to January 2018 Represents information of term specified for lease agreement. Lease Term From August 2015 To July 2016 [Member] Lease term from August 2015 to July 2016 Represents information of term specified for lease agreement. Lease Term From August 2016 To July 2017 [Member] Lease term from August 2016 to July 2017 Represents information of term specified for lease agreement. Lease Term From August 2017 To July 2018 [Member] August 2017 to January 2018 Represents information of term specified for lease agreement. Property Subject to or Available for Operating Lease [Line Items] Lessee, Operating Lease, Term of Contract Term specified for lease agreement Operating Lease, Payments Payments required per month under terms of lease agreement Lease Expense Lease expense Represented the difference between estimated cash payments on the lease and cash receipts from the sublease. Schedule of Long-term Debt Instruments [Table] Lender Name [Axis] Line of Credit Facility, Lender [Domain] Chang Family Trust [Member] Chang Family Trust Represents details of Chang Family Trust. Chang Family Trust One [Member] Chang Family Trust Represents Chang Family Trust. EX-101.PRE 10 smlr-20180630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Jun. 30, 2018	Jul. 31, 2018
Document And Entity Information [Abstract]
Entity Registrant Name	Semler Scientific, Inc.
Entity Central Index Key	0001554859
Trading Symbol	smlr
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		6,035,496
Document Type	10-Q
Document Period End Date	Jun. 30, 2018
Amendment Flag	false
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q2

XML 12 R2.htm IDEA: XBRL DOCUMENT

Condensed Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Income Statement [Abstract]
Revenues	$ 5,484	$ 2,578	$ 9,947	$ 4,633
Operating expenses:
Cost of revenues	680	592	1,384	1,131
Engineering and product development	489	474	856	913
Sales and marketing	1,779	1,164	3,484	2,153
General and administrative	1,001	902	1,875	1,740
Total operating expenses	3,949	3,132	7,599	5,937
Income (loss) from operations	1,535	(554)	2,348	(1,304)
Interest expense	(9)	(72)	(56)	(145)
Related party interest expense	(72)	(43)	(131)	(86)
Loss on extinguishment of loans		(179)		(179)
Other expense	(1)	(2)	(2)	(8)
Other expense	(82)	(296)	(189)	(418)
Net income (loss)	$ 1,453	$ (850)	$ 2,159	$ (1,722)
Net income (loss) per share:
Basic (in dollars per share)	$ 0.24	$ (0.16)	$ 0.36	$ (0.33)
Diluted (in dollars per share)	$ 0.19	$ (0.16)	$ 0.29	$ (0.33)
Weighted average number of shares used in computing: basic and diluted loss per share
Basic (in shares)	5,982,711	5,340,234	5,953,818	5,286,179
Diluted (in shares)	7,534,846	5,340,234	7,403,498	5,286,179

XML 13 R3.htm IDEA: XBRL DOCUMENT

Condensed Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2018	Dec. 31, 2017
Current Assets:
Cash	$ 2,009	$ 1,457
Trade accounts receivable, net of allowance for doubtful accounts of $35 and $35, respectively	1,850	1,315
Prepaid expenses and other current assets	216	111
Total current assets	4,075	2,883
Assets for lease, net	975	1,147
Property and equipment, net	247	193
Long-term deposits	15	15
Total assets	5,312	4,238
Current liabilities:
Accounts payable	185	488
Accrued expenses	2,256	2,670
Deferred revenue	535	531
Accrued interest		168
Accrued interest - related party	41	28
Loans payable net of debt discount of $0 and $9, respectively	44	1,018
Related party loans payable net of debt discount of $6 and $13, respectively	2,017	237
Total current liabilities	5,078	5,140
Long-term liabilities:
Deferred rent	12	13
Loans payable, less current portion	6	26
Related party loans payable, less current portion		1,642
Total long-term liabilities	18	1,681
Stockholders' equity (deficit):
Common stock, $0.001 par value; 50,000,000 shares authorized; 6,048,397 and 5,902,244 shares issued, and 6,023,397 and 5,877,244 outstanding (treasury shares of 25,000 and 25,000), respectively	6	6
Additional paid-in capital	24,484	23,843
Accumulated deficit	(24,274)	(26,432)
Total stockholders' equity (deficit)	216	(2,583)
Total liabilities and stockholders' equity (deficit)	$ 5,312	$ 4,238

XML 14 R4.htm IDEA: XBRL DOCUMENT

Condensed Balance Sheets (Parentheticals) - USD ($) $ in Thousands	Jun. 30, 2018	Dec. 31, 2017
Statement of Financial Position [Abstract]
Allowance for doubtful accounts on trade accounts receivable (in dollars)	$ 35	$ 35
Debt discount on loans payable, current (in dollars)	0	9
Debt discount on related party loans payable, current (in dollars)	$ 6	$ 13
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	6,048,397	5,902,244
Common stock, shares outstanding	6,023,397	5,877,244
Treasury stock, shares	25,000	25,000

XML 15 R5.htm IDEA: XBRL DOCUMENT

Condensed Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ 2,159	$ (1,722)
Reconciliation of Net Income (Loss) to Net Cash Provided by Operating Activities:
Amortization of debt discount	16	80
Accretion of non-cash interest	135	44
Loss on extinguishment of debt		179
Depreciation	249	267
Loss on disposal of assets for lease	107	142
Allowance for doubtful accounts	20	5
Stock-based compensation expense	331	165
Changes in Operating Assets and Liabilities:
Trade accounts receivable	(535)	(13)
Prepaid expenses and other current assets	(105)	(7)
Accounts payable	(303)	96
Accrued expenses	(570)	505
Deferred revenue	4	189
Net Cash Provided By (Used in) Operating Activities	1,508	(70)
CASH FLOWS FROM INVESTING ACTIVITIES:
Additions to property and equipment	(105)	(12)
Purchase of assets for lease	(138)	(591)
Net Cash Used in Investing Activities	(243)	(603)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock		475
Exercise of warrants	64
Exercise of stock options	245	78
Proceeds from loans payable		63
Payments of loans payable	(1,022)	(69)
Net Cash (Used in) Provided by Financing Activities	(713)	547
INCREASE (DECREASE) IN CASH	552	(126)
CASH, BEGINNING OF PERIOD	1,457	622
CASH, END OF PERIOD	2,009	496
Cash paid for interest	$ 191	7
Supplemental disclosure of noncash financing activity:
Reclassification of accrued interest to debt upon extinguishment		162
Fair value of warrants issued to lenders		$ 288

XML 16 R6.htm IDEA: XBRL DOCUMENT

Basis of Presentation

6 Months Ended

Jun. 30, 2018

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

Recently Issued Accounting Pronouncements

Accounting Pronouncements Recently Adopted

Accounting Pronouncements Not Yet Adopted

XML 17 R7.htm IDEA: XBRL DOCUMENT

Going Concern

6 Months Ended

Jun. 30, 2018

Going Concern [Abstract]

Going Concern

Going Concern

XML 18 R8.htm IDEA: XBRL DOCUMENT

Assets for Lease, net

6 Months Ended

Jun. 30, 2018

Leases, Capital [Abstract]

Assets for Lease, net

3.	Assets for Lease, net

Assets for lease consist of the following:

	June 30, 2018			December 31, 2017

Assets for lease	$	1,812		$	1,847
Less: accumulated depreciation		(837	)		(700	)
Assets for lease, net	$	975		$	1,147

XML 19 R9.htm IDEA: XBRL DOCUMENT

Property and Equipment, net

6 Months Ended

Jun. 30, 2018

Property, Plant and Equipment [Abstract]

Property and Equipment, net

Property and Equipment, net

Capital assets consist of the following:

	June 30, 2018			December 31, 2017

Capital assets	$	427		$	322
Less: accumulated depreciation		(180	)		(129	)
Capital assets, net	$	247		$	193

XML 20 R10.htm IDEA: XBRL DOCUMENT

Accrued Expenses

6 Months Ended

Jun. 30, 2018

Accrued Liabilities, Current [Abstract]

Accrued Expenses

5.	Accrued Expenses

Accrued expenses consist of the following:

	June 30, 2018		December 31, 2017

Compensation (1)	$	1,964	$	2,275
Board of directors fees (2)		15		148
Miscellaneous accruals		277		247
Total accrued expenses	$	2,256	$	2,670

____________

XML 21 R11.htm IDEA: XBRL DOCUMENT

Concentration of Credit Risk

6 Months Ended

Jun. 30, 2018

Risks and Uncertainties [Abstract]

Concentration of Credit Risk

Concentration of Credit Risk

XML 22 R12.htm IDEA: XBRL DOCUMENT

Facilities Leases

6 Months Ended

Jun. 30, 2018

Leases [Abstract]

Facilities Leases

7.	Facilities Leases

XML 23 R13.htm IDEA: XBRL DOCUMENT

Loans Payable

6 Months Ended

Jun. 30, 2018

Loans Payable [Abstract]

Loans Payable

Loans Payable

	June 30, 2018					December 31, 2017
Lender	Long-term		Short-term			Long-term		Short-term
Loans from Related Parties
Chang Family Trust			$	1,216		$	1,126
Chang Family Trust				557			516
Glenn J. Krevlin				250				$	250

Other Loans
Accredited Investor				-					700
Accredited Investor				-					160
Accredited Investor				-					80
Ascentium Capital, LLC				-					22
Ascentium Capital, LLC	$	4		28			16		26
Royal Bank America Leasing, L.P.				5					28
Ascentium Capital, LLC		2		11			10		11

Total		6		2,067			1,668		1,277
Debt Discounts		-		(6	)		-		(22	)
Total, net of debt discounts	$	6	$	2,061		$	1,668	$	1,255

Loans from Related Parties

Other Loans

	Three months ended June 30,						Six months ended June 30,
	2018			2017			2018			2017
Expected term (in years)		-			4.75			-			4.75
Risk-free interest rate		-	%		1.27	%		-	%		1.27	%
Expected volatility		-	%		104.6	%		-	%		104.6	%
Expected dividend rate		-	%		-	%		-	%		-	%

Indemnification Obligations

XML 24 R14.htm IDEA: XBRL DOCUMENT

Stock Option Plan

6 Months Ended

Jun. 30, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock Option Plan

Stock Option Plan

	Options Outstanding
	Number of Stock Options Outstanding			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (In Years)		Aggregate Intrinsic Value (in thousands)
Balance, January 1, 2018		1,855,138		$	2.69		7.48	$	9,850
Options granted		135,000			8.00
Options exercised		(105,378	)		2.32
Options forfeited/canceled		(6,410	)		3.44
Balance, June 30, 2018		1,878,350		$	3.09		7.23	$	23,216
Exercisable as of June 30, 2018		1,508,900		$	2.77		6.94	$	19,131

Determining the Fair Value of Stock Options

	Three months ended June 30,						Six months ended June 30,
	2018			2017			2018			2017
Expected term (in years)		-			5			5			5
Risk-free interest rate		-	%		1.94	%		2.2	%		1.94 – 2.02	%
Expected volatility		-	%		104.0	%		0.99	%		104.0 – 106.2	%
Expected dividend rate		-	%		-	%		-	%		-	%

The assumptions are based on the following for each of the periods presented:

Valuation Method — The Company estimates the fair value of its stock options using the Black-Scholes option pricing model.

Risk-free Interest Rate — The risk-free interest rate is based on median U.S. Treasury zero coupon issues with remaining terms similar to the expected term on the options.

	Three months ended June 30,				Six months ended June 30
	2018		2017		2018		2017
Cost of Revenue	$	1	$	1	$	1	$	1
Engineering and Product Development		9		12		17		24
Sales and Marketing		22		24		51		45
General and Administrative		106		50		262		95
Total	$	138	$	87	$	331	$	165

XML 25 R15.htm IDEA: XBRL DOCUMENT

Net Income (Loss) Per Share, Basic and Diluted

6 Months Ended

Jun. 30, 2018

Earnings Per Share [Abstract]

Net Income (Loss) Per Share, Basic and Diluted

10.

Net Income (Loss) Per Share, Basic and Diluted

Basic and diluted net EPS is calculated as follows:

	Three months ended June 30,
	2018						2017
	Shares		Net Income		EPS		Shares		Net Loss			EPS
Basic EPS		5,982,711	$	1,453	$	0.24		5,340,234	$	(850	)	$	(0.16	)
Common stock warrants		281,224		-				-		-
Common stock options		1,270,911		-				-		-
Diluted EPS		7,534,846	$	1,453	$	0.19		5,340,234	$	(850	)	$	(0.16	)

	Six months ended June 30,
	2018						2017
	Shares		Net Income		EPS		Shares		Net Loss			EPS
Basic EPS		5,953,818	$	2,159	$	0.36		5,286,179	$	(1,722	)	$	(0.33	)
Common stock warrants		256,916		-				-		-
Common stock options		1,195,010		-				-		-
Diluted EPS		7,403,498	$	2,159	$	0.29		5,286,179	$	(1,722	)	$	(0.33	)

	Three months ended June 30,				Six months ended June 30,
	2018		2017		2018		2017
Weighted average shares outstanding:
Common stock warrants		-		839,614		-		795,490
Options		135,000		2,040,322		135,000		2,120,936
Total		135,000		2,879,936		135,000		2,916,426

XML 26 R16.htm IDEA: XBRL DOCUMENT

Subsequent Events

6 Months Ended

Jun. 30, 2018

Subsequent Events [Abstract]

Subsequent Events

11.

Subsequent Events

None

XML 27 R17.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies and Estimates (Policies)

6 Months Ended

Jun. 30, 2018

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

Accounting Pronouncements Recently Adopted

Accounting Pronouncements Not Yet Adopted

XML 28 R18.htm IDEA: XBRL DOCUMENT

Assets for Lease, net (Tables)

6 Months Ended

Jun. 30, 2018

Leases, Capital [Abstract]

Schedule of assets for lease

	June 30, 2018			December 31, 2017

Assets for lease	$	1,812		$	1,847
Less: accumulated depreciation		(837	)		(700	)
Assets for lease, net	$	975		$	1,147

XML 29 R19.htm IDEA: XBRL DOCUMENT

Property and Equipment, net (Tables)

6 Months Ended

Jun. 30, 2018

Property, Plant and Equipment [Abstract]

Schedule of property and equipment, net

	June 30, 2018			December 31, 2017

Capital assets	$	427		$	322
Less: accumulated depreciation		(180	)		(129	)
Capital assets, net	$	247		$	193

XML 30 R20.htm IDEA: XBRL DOCUMENT

Accrued Expenses (Tables)

6 Months Ended

Jun. 30, 2018

Accrued Liabilities, Current [Abstract]

Schedule of accrued expenses

	June 30, 2018		December 31, 2017

Compensation (1)	$	1,964	$	2,275
Board of directors fees (2)		15		148
Miscellaneous accruals		277		247
Total accrued expenses	$	2,256	$	2,670

____________

XML 31 R21.htm IDEA: XBRL DOCUMENT

Loans Payable (Tables)

6 Months Ended

Jun. 30, 2018

Loans Payable [Abstract]

Schedule of loans payable

	June 30, 2018					December 31, 2017
Lender	Long-term		Short-term			Long-term		Short-term
Loans from Related Parties
Chang Family Trust			$	1,216		$	1,126
Chang Family Trust				557			516
Glenn J. Krevlin				250				$	250

Other Loans
Accredited Investor				-					700
Accredited Investor				-					160
Accredited Investor				-					80
Ascentium Capital, LLC				-					22
Ascentium Capital, LLC	$	4		28			16		26
Royal Bank America Leasing, L.P.				5					28
Ascentium Capital, LLC		2		11			10		11

Total		6		2,067			1,668		1,277
Debt Discounts		-		(6	)		-		(22	)
Total, net of debt discounts	$	6	$	2,061		$	1,668	$	1,255

Schedule for fair value of the warrants

	Three months ended June 30,						Six months ended June 30,
	2018			2017			2018			2017
Expected term (in years)		-			4.75			-			4.75
Risk-free interest rate		-	%		1.27	%		-	%		1.27	%
Expected volatility		-	%		104.6	%		-	%		104.6	%
Expected dividend rate		-	%		-	%		-	%		-	%

XML 32 R22.htm IDEA: XBRL DOCUMENT

Stock Option Plan (Tables)

6 Months Ended

Jun. 30, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of stock option activity

	Options Outstanding
	Number of Stock Options Outstanding			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (In Years)		Aggregate Intrinsic Value (in thousands)
Balance, January 1, 2018		1,855,138		$	2.69		7.48	$	9,850
Options granted		135,000			8.00
Options exercised		(105,378	)		2.32
Options forfeited/canceled		(6,410	)		3.44
Balance, June 30, 2018		1,878,350		$	3.09		7.23	$	23,216
Exercisable as of June 30, 2018		1,508,900		$	2.77		6.94	$	19,131

Schedule of weighted-average Black-Scholes fair value assumptions

	Three months ended June 30,						Six months ended June 30,
	2018			2017			2018			2017
Expected term (in years)		-			5			5			5
Risk-free interest rate		-	%		1.94	%		2.2	%		1.94 – 2.02	%
Expected volatility		-	%		104.0	%		0.99	%		104.0 – 106.2	%
Expected dividend rate		-	%		-	%		-	%		-	%

Schedule of stock-based compensation

	Three months ended June 30,				Six months ended June 30
	2018		2017		2018		2017
Cost of Revenue	$	1	$	1	$	1	$	1
Engineering and Product Development		9		12		17		24
Sales and Marketing		22		24		51		45
General and Administrative		106		50		262		95
Total	$	138	$	87	$	331	$	165

XML 33 R23.htm IDEA: XBRL DOCUMENT

Net Income (Loss) Per Share, Basic and Diluted (Tables)

6 Months Ended

Jun. 30, 2018

Earnings Per Share [Abstract]

Schedule of basic and diluted net EPS

	Three months ended June 30,
	2018						2017
	Shares		Net Income		EPS		Shares		Net Loss			EPS
Basic EPS		5,982,711	$	1,453	$	0.24		5,340,234	$	(850	)	$	(0.16	)
Common stock warrants		281,224		-				-		-
Common stock options		1,270,911		-				-		-
Diluted EPS		7,534,846	$	1,453	$	0.19		5,340,234	$	(850	)	$	(0.16	)

	Six months ended June 30,
	2018						2017
	Shares		Net Income		EPS		Shares		Net Loss			EPS
Basic EPS		5,953,818	$	2,159	$	0.36		5,286,179	$	(1,722	)	$	(0.33	)
Common stock warrants		256,916		-				-		-
Common stock options		1,195,010		-				-		-
Diluted EPS		7,403,498	$	2,159	$	0.29		5,286,179	$	(1,722	)	$	(0.33	)

Schedule of weighted average shares outstanding excluded from the computation of diluted net loss per share

	Three months ended June 30,				Six months ended June 30,
	2018		2017		2018		2017
Weighted average shares outstanding:
Common stock warrants		-		839,614		-		795,490
Options		135,000		2,040,322		135,000		2,120,936
Total		135,000		2,879,936		135,000		2,916,426

XML 34 R24.htm IDEA: XBRL DOCUMENT

Going Concern (Detail Textuals) - USD ($) $ in Thousands	Jun. 30, 2018	Dec. 31, 2017	Jun. 30, 2017	Dec. 31, 2016
Going Concern [Abstract]
Working capital deficit	$ 1,003
Cash	2,009	$ 1,457	$ 496	$ 622
Stockholders' equity	$ 216	$ (2,583)

XML 35 R25.htm IDEA: XBRL DOCUMENT

Assets for Lease, net - Summary of assets for lease (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Dec. 31, 2017
Leases, Capital [Abstract]
Assets for lease	$ 1,812	$ 1,847
Less: accumulated depreciation	(837)	(700)
Assets for lease, net	$ 975	$ 1,147

XML 36 R26.htm IDEA: XBRL DOCUMENT

Assets for Lease, net (Detail Textuals) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Leases, Capital [Abstract]
Depreciation expense	$ 101	$ 85	$ 198	$ 171
Reduction to accumulated depreciation for returned items	28	38	61	93
Loss on disposal of assets for lease	$ 38	$ 55	$ 107	$ 142

XML 37 R27.htm IDEA: XBRL DOCUMENT

Property and Equipment, net (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Dec. 31, 2017
Property, Plant and Equipment [Abstract]
Capital assets	$ 427	$ 322
Less: accumulated depreciation	(180)	(129)
Capital assets, net	$ 247	$ 193

XML 38 R28.htm IDEA: XBRL DOCUMENT

Property and Equipment, net (Detail Textuals) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 26	$ 47	$ 51	$ 95

XML 39 R29.htm IDEA: XBRL DOCUMENT

Accrued Expenses - Summary of accrued expenses (Details) - USD ($)
$ in Thousands

Jun. 30, 2018

Dec. 31, 2017

Accrued Liabilities, Current [Abstract]

Compensation

^[1]

$ 1,964

$ 2,275

Board of directors fees

^[2]

148

Miscellaneous accruals

277

247

Total accrued expenses

$ 2,256

$ 2,670

[1]

The balance of accrued compensation includes normal accruals for commissions, bonuses, paid time off and other accrued payroll items. In addition, three employees, including the Company's Chief Executive Officer ("CEO"), agreed to further defer amounts accrued to them as of December 31, 2017. The Company agreed to further delay and continue to accrue these amounts and increase the balance owed by 1% per month beginning January 1, 2017 to no later than January 31, 2019. As of June 30, 2018, the deferred amounts plus additional 1% accruals owed to the CEO were paid in full and the balance was $0.

[2]

Two members of the Company's board of directors agreed to further defer fees earned from August 2016 to July 2017. The Company agreed to further delay and continue to accrue these amounts and increase the balance owed by 1% per month beginning January 1, 2018 to no later than January 1, 2019. As of June 30, 2018, these deferred amounts plus additional 1% accruals were paid in full and the balance was $0.

XML 40 R30.htm IDEA: XBRL DOCUMENT

Accrued Expenses (Detail Textuals) $ in Thousands	6 Months Ended
Accrued Expenses (Detail Textuals) $ in Thousands	Jun. 30, 2018 USD ($)
Accrued Liabilities, Current [Abstract]
Percentage increase in balance owed per month	1.00%
Deferred amounts plus additional 1% accruals	$ 0

XML 41 R31.htm IDEA: XBRL DOCUMENT

Concentration of Credit Risk (Detail Textuals) - Customer concentration risk - Customer	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Dec. 31, 2017
Revenue
Concentration Risk [Line Items]
Number of customers	2	1	2	1
Revenue \| Customer one
Concentration Risk [Line Items]
Concentration risk percentage	50.30%	56.10%	53.90%	56.70%
Revenue \| Customer two
Concentration Risk [Line Items]
Concentration risk percentage	22.50%		17.70%
Accounts receivable
Concentration Risk [Line Items]
Number of customers			2		2
Accounts receivable \| Customer one
Concentration Risk [Line Items]
Concentration risk percentage			45.10%		56.60%
Accounts receivable \| Customer two
Concentration Risk [Line Items]
Concentration risk percentage			37.70%		23.90%

XML 42 R32.htm IDEA: XBRL DOCUMENT

Facilities Leases (Detail Textuals) - USD ($)	3 Months Ended		6 Months Ended
Facilities Leases (Detail Textuals) - USD ($)	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Jul. 15, 2015	Sep. 23, 2014
Property Subject to or Available for Operating Lease [Line Items]
Lease expense	$ 18,000	$ 17,000	$ 35,000	$ 34,000
Lease Agreement
Property Subject to or Available for Operating Lease [Line Items]
Term specified for lease agreement						36 months
Lease Agreement \| Lease term from February 2015 to January 2016
Property Subject to or Available for Operating Lease [Line Items]
Payments required per month under terms of lease agreement			17,000
Lease Agreement \| Lease term from February 2016 to January 2017
Property Subject to or Available for Operating Lease [Line Items]
Payments required per month under terms of lease agreement			17,500
Lease Agreement \| Lease term from February 2017 to January 2018
Property Subject to or Available for Operating Lease [Line Items]
Payments required per month under terms of lease agreement			18,000
Sub Lease Agreement
Property Subject to or Available for Operating Lease [Line Items]
Term specified for lease agreement					30 months
Sub Lease Agreement \| Lease term from August 2015 to July 2016
Property Subject to or Available for Operating Lease [Line Items]
Payments required per month under terms of lease agreement			15,500
Sub Lease Agreement \| Lease term from August 2016 to July 2017
Property Subject to or Available for Operating Lease [Line Items]
Payments required per month under terms of lease agreement			16,000
Sub Lease Agreement \| August 2017 to January 2018
Property Subject to or Available for Operating Lease [Line Items]
Payments required per month under terms of lease agreement			$ 16,500

XML 43 R33.htm IDEA: XBRL DOCUMENT

Loans Payable (Details) - USD ($) $ in Thousands	Jun. 30, 2018	Dec. 31, 2017
Debt Instrument [Line Items]
Long-term, Total	$ 6	$ 1,668
Long-term, Debt Discounts	0	0
Long-term, Total, net of debt discounts	6	1,668
Short-term, Total	2,067	1,277
Short-term, Debt Discounts	(6)	(22)
Short-term, Total, net of debt discounts	2,061	1,255
Chang Family Trust
Debt Instrument [Line Items]
Long-term, Total		1,126
Short-term, Total	1,216
Chang Family Trust
Debt Instrument [Line Items]
Long-term, Total		516
Short-term, Total	557
Glen J. Krevlin
Debt Instrument [Line Items]
Short-term, Total	250	250
Accredited investor
Debt Instrument [Line Items]
Short-term, Total	0	700
Accredited Investor
Debt Instrument [Line Items]
Short-term, Total	0	160
Accredited Investor
Debt Instrument [Line Items]
Short-term, Total	0	80
Ascentium Capital, LLC
Debt Instrument [Line Items]
Short-term, Total	0	22
Ascentium Capital, LLC
Debt Instrument [Line Items]
Long-term, Total	4	16
Short-term, Total	28	26
Royal Bank America Leasing, L.P.
Debt Instrument [Line Items]
Short-term, Total	5	28
Ascentium Capital, LLC
Debt Instrument [Line Items]
Long-term, Total	2	10
Short-term, Total	$ 11	$ 11

XML 44 R34.htm IDEA: XBRL DOCUMENT

Loans Payable (Details 1)	3 Months Ended		6 Months Ended
Loans Payable (Details 1)	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Expected term (in years)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Expected term		4 years 9 months		4 years 9 months
Risk-free interest rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants measurement input	0.00%	1.27%	0.00%	1.27%
Expected volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants measurement input	0.00%	104.60%	0.00%	104.60%
Expected dividend rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants measurement input	0.00%	0.00%	0.00%	0.00%

XML 45 R35.htm IDEA: XBRL DOCUMENT

Loans Payable (Detail Textuals) - USD ($) $ / shares in Units, $ in Thousands				1 Months Ended				3 Months Ended	6 Months Ended
	May 02, 2017	Apr. 05, 2016	Jan. 15, 2016	Nov. 21, 2016	May 20, 2016	Mar. 31, 2016	Jan. 21, 2016	Jun. 30, 2017	Jun. 30, 2017
Debt Instrument [Line Items]
Loss on extinguishment of debt								$ (179)	$ (179)
Unsecured loan \| Loan Agreement \| Accredited investor
Debt Instrument [Line Items]
Amount of loan obtained		$ 160			$ 80	$ 700
Term of loan		24 months			24 months	24 months
Percentage of interest rates		10.00%			10.00%	10.00%
Monthly principal plus accrued interest payment		$ 160			$ 80	$ 700
Warrant term		2 years			2 years	2 years
Number of common stock issued against warrants exercised		18,162			9,081	79,459
Exercise price per warrants		$ 1.85			$ 1.85	$ 1.85
Minimum percentage holding required by holder to retain exercising rights		more than 4.99%			more than 4.99%	more than 4.99%
Number of warrant issued to purchase common stock					7,323
Unsecured loan \| Loan Agreement \| Glen J. Krevlin
Debt Instrument [Line Items]
Amount of loan obtained				$ 250
Term of loan				24 months
Percentage of interest rates				10.00%
Monthly principal plus accrued interest payment				$ 250
Warrant term				2 years
Number of common stock issued against warrants exercised				28,378
Exercise price per warrants				$ 1.85
Minimum percentage holding required by holder to retain exercising rights				more than 9.99%
Unsecured loan \| Loan Agreement \| Chang Family Trust
Debt Instrument [Line Items]
Amount of loan obtained			$ 1,000				$ 500
Term of loan			24 months				24 months
Percentage of interest rates			10.00%				5.00%
Monthly principal plus accrued interest payment			$ 1,000				$ 500
Additional indebtness			$ 50				$ 50
Warrant term			2 years				2 years
Number of common stock issued against warrants exercised			114,286				114,286
Exercise price per warrants			$ 1.75				$ 1.75
Unsecured loan \| Amended loan agreement \| Chang Family Trust
Debt Instrument [Line Items]
Term of loan	2 years
Warrant term	3 years
Number of common stock issued against warrants exercised	134,616
Exercise price per warrants	$ 2.60
Specific portion of notes on which rate of interest increased	$ 500
Rate of interest charged on specific portion of note	10.00%
Minimum percentage holding required by holder to retain exercising rights	more than 19.99%
Loss on extinguishment of debt	$ 179

XML 46 R36.htm IDEA: XBRL DOCUMENT

Loans Payable (Detail Textuals 1) - USD ($)					3 Months Ended		6 Months Ended
Loans Payable (Detail Textuals 1) - USD ($)	Apr. 01, 2017	Oct. 02, 2016	Jul. 11, 2016	Jul. 08, 2016	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Debt Instrument [Line Items]
Fair value of warrants with promissory notes						$ 288,000		$ 288,000
Interest expense					$ 82,000	115,000	$ 187,000	231,000
Amortization of debt discount					$ 4,000	$ 28,000	$ 16,000	$ 80,000
Software license financing agreement \| Ascentium Capital, LLC
Debt Instrument [Line Items]
Amount of loan obtained	$ 63,000			$ 74,000
Term of loan	12 months			36 months
Percentage of interest rates	10.30%			8.90%
Loan principal and interest payment	$ 5,600			$ 2,400
Secured equipment financing agreement \| Royal Bank America Leasing, L.P.
Debt Instrument [Line Items]
Amount of loan obtained			$ 140,000
Term of loan			36 months
Percentage of interest rates			7.30%
First installment			$ 37,000
Second installment disbursed in July 2017			47,000
Third installment disbursed in July 2018			56,000
Secured equipment financing agreement \| Royal Bank America Leasing, L.P. \| July 2016 through July 2017
Debt Instrument [Line Items]
Third installment disbursed in July 2018			3,500
Secured equipment financing agreement \| Royal Bank America Leasing, L.P. \| July 2017 through July 2018
Debt Instrument [Line Items]
Third installment disbursed in July 2018			4,400
Secured equipment financing agreement \| Royal Bank America Leasing, L.P. \| July 2018 through July 2019
Debt Instrument [Line Items]
Third installment disbursed in July 2018			$ 5,300
Secured equipment financing agreement \| Ascentium Capital, LLC
Debt Instrument [Line Items]
Amount of loan obtained		$ 33,000
Term of loan		36 months
Percentage of interest rates		9.10%
Loan principal and interest payment		$ 1,000

XML 47 R37.htm IDEA: XBRL DOCUMENT

Stock Option Plan - Summary of stock-based compensation activity (Details) - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2018	Dec. 31, 2017
Number of Stock Options Outstanding
Balance, January 1, 2018	1,855,138
Options granted	135,000
Options exercised	(105,378)
Options forfeited/canceled	(6,410)
Balance, June 30, 2018	1,878,350	1,855,138
Exercisable as of June 30, 2018	1,508,900
Weighted Average Exercise Price
Balance, January 1, 2018	$ 2.69
Options granted	8.00
Options exercised	2.32
Options forfeited/canceled	3.44
Balance, June 30, 2018	3.09	$ 2.69
Exercisable as of June 30, 2018	$ 2.77
Weighted Average Remaining Contractual Term, Options Outstanding (in years)	7 years 2 months 23 days	7 years 5 months 23 days
Weighted Average Remaining Contractual Term, Options Exercisable (in years)	6 years 11 months 9 days
Aggregate Intrinsic Value, Options Outstanding	$ 23,216	$ 9,850
Aggregate Intrinsic Value, Options Exercisable	$ 19,131

XML 48 R38.htm IDEA: XBRL DOCUMENT

Stock Option Plan - Weighted-average Black-Scholes fair value assumptions (Details 1)	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)		5 years	5 years	5 years
Risk free interest rate	0.00%	1.94%	2.20%
Expected volatility	0.00%	104.00%	0.99%
Expected dividend rate	0.00%	0.00%	0.00%	0.00%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk free interest rate				1.94%
Expected volatility				104.00%
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk free interest rate				2.02%
Expected volatility				106.20%

XML 49 R39.htm IDEA: XBRL DOCUMENT

Stock Option Plan - Stock-based compensation (Details 2) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 138	$ 87	$ 331	$ 165
Cost of Revenue
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	1	1	1	1
Engineering and Product Development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	9	12	17	24
Sales and Marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	22	24	51	45
General and Administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 106	$ 50	$ 262	$ 95

XML 50 R40.htm IDEA: XBRL DOCUMENT

Stock Option Plan (Detail Textuals) - USD ($) $ / shares in Units, $ in Thousands		1 Months Ended					3 Months Ended		6 Months Ended
	Jan. 02, 2018	Jan. 31, 2018	Jan. 31, 2017	Jan. 31, 2016	Oct. 31, 2015	Jan. 31, 2015	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost related to non-vested stock options							$ 1,184		$ 1,184
Weighted average period of unvested stock awards									2 years 2 months 19 days
Weighted average grant date fair value of options granted									$ 5.97	$ 1.52
Aggregate grant date fair value									$ 806	$ 269
One-time expense									39
Stock-based compensation expense							$ 138	$ 87	$ 331	$ 165
2007 Key Person Stock Option Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for future stock-based compensation grants							0		0
Aggregate number of common shares reserved for future issuance							407,500		407,500
2014 Stock Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for future stock-based compensation grants							987,337		987,337
Aggregate number of common shares reserved for future issuance							2,783,616		2,783,616
2014 Stock Incentive Plan \| Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum number of shares issued pursuant to awards granted under plan							450,000		450,000
Maximum term of stock option grants					10 years
Number of share reserve increased		235,090	204,943	204,943	1,500,000	188,640
Percentage of shares reserve increased		4.00%	4.00%	4.00%	4.00%	4.00%
2014 Stock Incentive Plan \| Stock options \| Board of Directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for future stock-based compensation grants	125,000
Percentage of shares vested on one year anniversary	25.00%
Number of years in options fully vested	4 years
2014 Stock Incentive Plan \| Stock options \| Non Employee Directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for future stock-based compensation grants	5,000
Maximum number of shares issued pursuant to awards granted under plan	10,000
Number of years in options fully vested	1 year

XML 51 R41.htm IDEA: XBRL DOCUMENT

Net Income (Loss) Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Earnings Per Share [Abstract]
Basic EPS (in shares)	5,982,711	5,340,234	5,953,818	5,286,179
Common stock warrants (in shares)	281,224	0	256,916	0
Common stock options (in shares)	1,270,911	0	1,195,010	0
Diluted EPS (in shares)	7,534,846	5,340,234	7,403,498	5,286,179
Net Income - Basic EPS	$ 1,453	$ (850)	$ 2,159	$ (1,722)
Net Income - Common stock warrants	0	0	0	0
Net Income - Common stock options	0	0	0	0
Net Income - Diluted EPS	$ 1,453	$ (850)	$ 2,159	$ (1,722)
Basic EPS (in dollars per share)	$ 0.24	$ (0.16)	$ 0.36	$ (0.33)
Diluted EPS (in dollars per share)	$ 0.19	$ (0.16)	$ 0.29	$ (0.33)

XML 52 R42.htm IDEA: XBRL DOCUMENT

Net Income (Loss) Per Share, Basic and Diluted (Details 1) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Weighted average shares outstanding:
Total	135,000	2,879,936	135,000	2,916,426
Common stock warrants
Weighted average shares outstanding:
Total	0	839,614	0	795,490
Options
Weighted average shares outstanding:
Total	135,000	2,040,322	135,000	2,120,936

EXCEL 53 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 54 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 55 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 57 FilingSummary.xml IDEA: XBRL DOCUMENT 3.10.0.1 html 131 191 1 true 53 0 false 5 false false R1.htm 001 - Document - Document and Entity Information Sheet http://semlerscientific.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 002 - Statement - Condensed Statements of Operations (Unaudited) Sheet http://semlerscientific.com/role/CondensedStatementsOfOperationsUnaudited Condensed Statements of Operations (Unaudited) Statements 2 false false R3.htm 003 - Statement - Condensed Balance Sheets Sheet http://semlerscientific.com/role/CondensedBalanceSheets Condensed Balance Sheets Statements 3 false false R4.htm 004 - Statement - Condensed Balance Sheets (Parentheticals) Sheet http://semlerscientific.com/role/CondensedBalanceSheetsParentheticals Condensed Balance Sheets (Parentheticals) Statements 4 false false R5.htm 005 - Statement - Condensed Statements of Cash Flows (Unaudited) Sheet http://semlerscientific.com/role/CondensedStatementsOfCashFlowsUnaudited Condensed Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 006 - Disclosure - Basis of Presentation Sheet http://semlerscientific.com/role/BasisOfPresentation Basis of Presentation Notes 6 false false R7.htm 007 - Disclosure - Going Concern Sheet http://semlerscientific.com/role/GoingConcern Going Concern Notes 7 false false R8.htm 008 - Disclosure - Assets for Lease, net Sheet http://semlerscientific.com/role/AssetsForLeaseNet Assets for Lease, net Notes 8 false false R9.htm 009 - Disclosure - Property and Equipment, net Sheet http://semlerscientific.com/role/PropertyAndEquipmentNet Property and Equipment, net Notes 9 false false R10.htm 010 - Disclosure - Accrued Expenses Sheet http://semlerscientific.com/role/AccruedExpenses Accrued Expenses Notes 10 false false R11.htm 011 - Disclosure - Concentration of Credit Risk Sheet http://semlerscientific.com/role/ConcentrationOfCreditRisk Concentration of Credit Risk Notes 11 false false R12.htm 012 - Disclosure - Facilities Leases Sheet http://semlerscientific.com/role/FacilitiesLeases Facilities Leases Notes 12 false false R13.htm 013 - Disclosure - Loans Payable Sheet http://semlerscientific.com/role/LoansPayable Loans Payable Notes 13 false false R14.htm 014 - Disclosure - Stock Option Plan Sheet http://semlerscientific.com/role/StockOptionPlan Stock Option Plan Notes 14 false false R15.htm 015 - Disclosure - Net Income (Loss) Per Share, Basic and Diluted Sheet http://semlerscientific.com/role/NetLossPerShareBasicAndDiluted Net Income (Loss) Per Share, Basic and Diluted Notes 15 false false R16.htm 016 - Disclosure - Subsequent Events Sheet http://semlerscientific.com/role/SubsequentEvents Subsequent Events Notes 16 false false R17.htm 017 - Disclosure - Summary of Significant Accounting Policies and Estimates (Policies) Sheet http://semlerscientific.com/role/SummaryofSignificantAccountingPoliciesandEstimatesPolicies Summary of Significant Accounting Policies and Estimates (Policies) Policies 17 false false R18.htm 018 - Disclosure - Assets for Lease, net (Tables) Sheet http://semlerscientific.com/role/AssetsForLeaseNetTables Assets for Lease, net (Tables) Tables http://semlerscientific.com/role/AssetsForLeaseNet 18 false false R19.htm 019 - Disclosure - Property and Equipment, net (Tables) Sheet http://semlerscientific.com/role/PropertyAndEquipmentNetTables Property and Equipment, net (Tables) Tables http://semlerscientific.com/role/PropertyAndEquipmentNet 19 false false R20.htm 020 - Disclosure - Accrued Expenses (Tables) Sheet http://semlerscientific.com/role/AccruedExpensesTables Accrued Expenses (Tables) Tables http://semlerscientific.com/role/AccruedExpenses 20 false false R21.htm 021 - Disclosure - Loans Payable (Tables) Sheet http://semlerscientific.com/role/LoansPayableTables Loans Payable (Tables) Tables http://semlerscientific.com/role/LoansPayable 21 false false R22.htm 022 - Disclosure - Stock Option Plan (Tables) Sheet http://semlerscientific.com/role/StockOptionPlanTables Stock Option Plan (Tables) Tables http://semlerscientific.com/role/StockOptionPlan 22 false false R23.htm 023 - Disclosure - Net Income (Loss) Per Share, Basic and Diluted (Tables) Sheet http://semlerscientific.com/role/NetlosspersharebasicanddilutedTables Net Income (Loss) Per Share, Basic and Diluted (Tables) Tables http://semlerscientific.com/role/NetLossPerShareBasicAndDiluted 23 false false R24.htm 024 - Disclosure - Going Concern (Detail Textuals) Sheet http://semlerscientific.com/role/GoingConcernDetailTextuals Going Concern (Detail Textuals) Details http://semlerscientific.com/role/GoingConcern 24 false false R25.htm 025 - Disclosure - Assets for Lease, net - Summary of assets for lease (Details) Sheet http://semlerscientific.com/role/AssetsForLeaseNetSummaryOfAssetsForLeaseDetails Assets for Lease, net - Summary of assets for lease (Details) Details 25 false false R26.htm 026 - Disclosure - Assets for Lease, net (Detail Textuals) Sheet http://semlerscientific.com/role/AssetsForLeaseNetDetailTextuals Assets for Lease, net (Detail Textuals) Details http://semlerscientific.com/role/AssetsForLeaseNetTables 26 false false R27.htm 027 - Disclosure - Property and Equipment, net (Details) Sheet http://semlerscientific.com/role/PropertyAndEquipmentNetDetails Property and Equipment, net (Details) Details http://semlerscientific.com/role/PropertyAndEquipmentNetTables 27 false false R28.htm 028 - Disclosure - Property and Equipment, net (Detail Textuals) Sheet http://semlerscientific.com/role/PropertyAndEquipmentNetDetailTextuals Property and Equipment, net (Detail Textuals) Details http://semlerscientific.com/role/PropertyAndEquipmentNetTables 28 false false R29.htm 029 - Disclosure - Accrued Expenses - Summary of accrued expenses (Details) Sheet http://semlerscientific.com/role/AccruedExpensesSummaryOfAccruedExpensesDetails Accrued Expenses - Summary of accrued expenses (Details) Details 29 false false R30.htm 030 - Disclosure - Accrued Expenses (Detail Textuals) Sheet http://semlerscientific.com/role/AccruedExpensesDetailsTextuals Accrued Expenses (Detail Textuals) Details http://semlerscientific.com/role/AccruedExpensesTables 30 false false R31.htm 031 - Disclosure - Concentration of Credit Risk (Detail Textuals) Sheet http://semlerscientific.com/role/ConcentrationOfCreditRiskDetailTextuals Concentration of Credit Risk (Detail Textuals) Details http://semlerscientific.com/role/ConcentrationOfCreditRisk 31 false false R32.htm 032 - Disclosure - Facilities Leases (Detail Textuals) Sheet http://semlerscientific.com/role/FacilitiesLeasesDetailTextuals Facilities Leases (Detail Textuals) Details http://semlerscientific.com/role/FacilitiesLeases 32 false false R33.htm 033 - Disclosure - Loans Payable (Details) Sheet http://semlerscientific.com/role/LoansPayableDetails Loans Payable (Details) Details http://semlerscientific.com/role/LoansPayableTables 33 false false R34.htm 034 - Disclosure - Loans Payable (Details 1) Sheet http://semlerscientific.com/role/LoansPayableDetails1 Loans Payable (Details 1) Details http://semlerscientific.com/role/LoansPayableTables 34 false false R35.htm 035 - Disclosure - Loans Payable (Detail Textuals) Sheet http://semlerscientific.com/role/LoansPayableDetailTextuals Loans Payable (Detail Textuals) Details http://semlerscientific.com/role/LoansPayableTables 35 false false R36.htm 036 - Disclosure - Loans Payable (Detail Textuals 1) Sheet http://semlerscientific.com/role/LoansPayableDetailTextuals1 Loans Payable (Detail Textuals 1) Details http://semlerscientific.com/role/LoansPayableTables 36 false false R37.htm 037 - Disclosure - Stock Option Plan - Summary of stock-based compensation activity (Details) Sheet http://semlerscientific.com/role/StockOptionPlanSummaryOfStockBasedCompensationActivityDetails Stock Option Plan - Summary of stock-based compensation activity (Details) Details 37 false false R38.htm 038 - Disclosure - Stock Option Plan - Weighted-average Black-Scholes fair value assumptions (Details 1) Sheet http://semlerscientific.com/role/StockOptionPlanWeightedAverageBlackScholesFairValueAssumptionsDetails1 Stock Option Plan - Weighted-average Black-Scholes fair value assumptions (Details 1) Details 38 false false R39.htm 039 - Disclosure - Stock Option Plan - Stock-based compensation (Details 2) Sheet http://semlerscientific.com/role/StockOptionPlanStockBasedCompensationDetails2 Stock Option Plan - Stock-based compensation (Details 2) Details 39 false false R40.htm 040 - Disclosure - Stock Option Plan (Detail Textuals) Sheet http://semlerscientific.com/role/StockOptionPlanDetailTextuals Stock Option Plan (Detail Textuals) Details http://semlerscientific.com/role/StockOptionPlanTables 40 false false R41.htm 041 - Disclosure - Net Income (Loss) Per Share, Basic and Diluted (Details) Sheet http://semlerscientific.com/role/NetLossPerCommonShareDetails Net Income (Loss) Per Share, Basic and Diluted (Details) Details http://semlerscientific.com/role/NetlosspersharebasicanddilutedTables 41 false false R42.htm 042 - Disclosure - Net Income (Loss) Per Share, Basic and Diluted (Details 1) Sheet http://semlerscientific.com/role/NetLossPerCommonShareDetails1 Net Income (Loss) Per Share, Basic and Diluted (Details 1) Details http://semlerscientific.com/role/NetlosspersharebasicanddilutedTables 42 false false All Reports Book All Reports smlr-20180630.xml smlr-20180630.xsd smlr-20180630_cal.xml smlr-20180630_def.xml smlr-20180630_lab.xml smlr-20180630_pre.xml http://fasb.org/srt/2018-01-31 http://fasb.org/us-gaap/2018-01-31 http://xbrl.sec.gov/dei/2018-01-31 true true ZIP 59 0001144204-18-041786-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-18-041786-xbrl.zip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end